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Abstract 
DJ-1 is a multifunctional protein linked to familial Parkinson’s disease. DJ-1 has been 
suggested to exert its cytoprotective function, in part, by acting as a copper carrier that 
can sequester the reactive metal and/or provide the copper cofactor for the activation of 
the Cu-Zn superoxide dismutase (SOD1). Using absorption spectroscopy and mass 
spectrometry, we found that DJ-1 binds one Cu(I) ion per DJ-1 homodimer. The 
structure of Cu(I)-bound DJ-1 reveals a new biscysteinate metal binding motif formed 
by juxtaposed Cys-53 at the homodimer interface. We calculated a subfemtomolar 
dissociation constant (Kd = 6.41 x 10
-16
 M) for Cu(I) that supports the physiological 
intracellular retention of the metal. Cu(I)-bound DJ-1 was not capable of interacting and 
activating SOD1 in vitro. We posit that DJ-1 sequester copper to protect against metal-
induced cytotoxicity. Our results illuminate the molecular basis on how disease-linked 
mutations that impairs homodimerisation could disrupt the metal binding site. 
 
In the second part of this dissertation, we sought to determine the impact of a 
Parkinsonism-linked A107P mutation on DJ-1 structure and glyoxalase activity. The 
A107P variant abrogates the ability of DJ-1 to protect against glyoxal-induced 
cytotoxicity and carboxymethyllysine protein modification. A crystal structure of DJ-1 
C106S variant with glycerol and sulphate bound in the active site suggests that Ala-107 
is critical for the stabilization of the transition state of the nucleophilic addition step. In 
our hands, the protein levels of DJ-1 A107P mutant in SH-SH5Y cells were ostensibly 
similar to the wild-type level but reduced levels were found in HEK 293E and MEF 
cells. Using CD and NMR spectroscopy, we found that the structural defect caused by 
the mutation extends beyond the active site. The A107P mutation resulted in a 
remarkable misfolding of the protein providing a basis for the reduced intracellular 
protein level and the abrogation of enzymatic activity.  
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1.1 Introduction to Parkinson’s disease 
1.1.1 Parkinson’s disease 
In 1817, James Parkinson, a surgeon in London, wrote the famous monograph “An 
Essay of Shaking Palsy” where he defined a pathological condition that affected six 
patients with a progressive deficit in controlling bodily movements (reviewed by 
Critchley, 1955). His description of the malady states: 
“Involuntary tremulous motion, with lessened muscular power, in parts not in action 
and even when supported; with a propensity to bend the trunk forwards, and to pass 
from walking to a running pace; the senses and intellects being uninjured”. 
Most of these classical motor symptoms e.g. tremor at rest, rigidity (increased muscular 
tone), bradykinesia (slowness of movement) and postural instability remain as the 
cardinal basis for the diagnosis of a spectrum of chronic movement disorders termed 
parkinsonism, with Parkinson’s disease (PD) or primary parkinsonism being the most 
common form (Dauer and Przedborski, 2003).  
PD affects at least 4 million people worldwide (Dorsey et al., 2007). Its incidence 
increases with age, with 1 - 2% of the population aged over 65 years likely to be 
affected by the disease (Eriksen et al., 2005a). PD remains incurable and current 
treatments have limitations. The development of new therapies is held back by our 
inadequate knowledge of physiological pathways that trigger the onset of the disease. 
As the ageing population expands, many countries realise the need for fundamental 
understanding of PD pathogenesis and the development of new therapies that can 
improve symptoms and delay disease progression. 
1.1.2 Pathophysiology of PD 
Pathological studies of PD gained impetus when Nobel Laureate Arvid Carlsson 
discovered dopamine (Carlsson et al., 1957). Dopamine is a neurotransmitter 
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synthesised from L-tyrosine by specific sets of neurons to signal either an excitatory or 
inhibitory output. PD is a neurodegenerative disease caused by the marked deterioration 
of dopamine-producing neurons in the specific area of the midbrain called the 
Substantia Nigra pars compacta (SNpc).  
The SNpc is part of the basal ganglia motor circuitry that modulates movement e.g. 
muscle contraction, multi-joint movements, muscle force and the sequence of 
movements (Dauer and Przedborski, 2003; Lewis et al., 2003). SNpc neurons form the 
nigrostriatal pathway that connects the substantia nigra to the striatum (Figure 1). Their 
synapses mainly provide dopaminergic input to the putamen through direct and indirect 
pathways to produce a regulated motor output. In the direct pathway, dopamine acts as 
an excitatory neurotransmitter to the putamen through D2 dopamine receptors. The 
putamen directly inhibits the Globus Pallidus internus (GPi) allowing the motor cortex 
to signal movement. In the indirect pathway, dopamine acts as an inhibitory 
neurotransmitter to the putamen through D1 dopamine receptors resulting in an 
excitatory output to the GPi indirectly via the Globus Pallidus externus and the 
subthalamic nucleus. The direct and indirect pathways work in synergy to fine tune 
movement (reviewed by Dauer and Przedborski, 2003; Lewis et al., 2003; Eriksen et al., 
2005a). 
In PD, 60% of the SNpc neurons are lost which leads to 80% depletion of striatal 
dopamine (Fearnly and Lees, 1991). The deficiency of dopaminergic input to the 
putamen results in attenuated inhibition of GPi by the direct pathway with a 
concomitant abnormal increase in excitatory output on GPi by the indirect pathway; the 
combined action triggering an impaired movement observed in Parkinson’s disease 
(Figure 1; Lewis et al., 2003).  
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Figure 1. Nigrostriatal pathway. Left panel: SNpc neurons provide dopaminergic 
input to the putamen through direct (solid arrows) and indirect (broken arrows) 
pathways. Red and blue arrows indicate excitatory and inhibitory outputs, respectively.  
Right panel: Nigrostrial pathway affected with Parkinson’s disease.  Arrow widths are 
altered to reflect decrease and increase in signal output. 
Neuronal loss observed in PD extends well beyond the dopaminergic neurons of SNpc. 
Lesions are found in the cerebral cortex, cholinergic (dorsal motor nucleus of vagus, 
nucleus basalis of Meynert), serotonergic (raphe), and noradrenergic (locus coeruleus) 
systems which account for the non-motor symptoms that are associated with PD 
(Jellinger, 1991; Jellinger, 2001). 
Aside from the loss of nigrostriatal dopaminergic neurons, another hallmark of PD is 
the presence of neuronal proteinacious inclusions called Lewy bodies (LB). These are 
spherical cytoplasmic deposits rich in a protein called α-synuclein and are usually found 
in affected brain regions (Gibbs and Lees, 1988). The role of LB in PD pathogenesis is 
not clear and it remains unresolved whether the post-mortem identification of LB is 
necessary for a definitive diagnosis of PD since some patients lack LB yet are still 
considered to have PD. 
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1.1.3 Pathways associated with PD pathogenesis 
1.1.3.1 Oxidative stress 
Oxidative stress occurs when an imbalance exists between the levels of reactive oxygen 
species (ROS) and the antioxidant capacity of the cell, whereby the former overwhelms 
the latter, leading to a deleterious damage to cells. ROS are endogenously produced as 
byproducts of normal metabolism, however, pathological processes such as 
mitochondrial dysfunction (Lin and Beal, 2006), reactive metal mishandling (Halliwell, 
2006), and inflammation (Johnstone et al., 1999) can significantly contribute to 
deleterious levels. A list of biologically relevant ROS is shown in Table 1. 
                          Table 1. Reactive oxygen species 
Radicals Nonradicals 
Superoxide, O2
•- 
Hydrogen peroxide, H2O2 
Hydroxyl, HO
• 
Organic peroxides, ROOH 
Peroxyl, RO2
• 
 
Alkoxyl, RO
• 
 
Hydroperoxyl, HO2
• 
 
                               R = organic moiety 
Oxidative stress has been intimately linked to the development of Parkinson’s disease 
(Jenner and Olanow, 1996). Post-mortem histopathological examinations of PD 
patients’ brains have provided evidence of the wide-spread effects of oxidative stress in 
the affected brain regions including decreased levels of the antioxidant glutathione, lipid 
peroxidation, increased neuromelanin production, DNA damage and protein oxidation 
(Dexter et al. 1989; Jenner and Olanow, 1996; Faucheux et al. 2003). 
Animal studies using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 6-
hydroxydopamine (OHDA), neurotoxins that selectively kill dopaminergic neurons, 
support a role for an oxidative stress pathway to pathogenesis. MPTP is converted to a 
neurotoxic form MPP+ that can be absorbed selectively by dopaminergic neurons 
(Javitch and Snyder, 1984; Langston et al., 1984). Superoxide radicals are produced by 
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MPP+ by inhibiting the mitochondrial electron transport chain complex I (Cleeter et al., 
1992). MPP+ can also contribute to an increase in free radical formation by inducing the 
inflammatory cascade (Wu et al., 2003). The neurotoxicity of OHDA is also attributed 
to its ability to produce ROS such as superoxide radical, hydrogen peroxide, and 
hydroxyl radicals when it undergoes auto-oxidation (Cohen and Heikkila, 1974; Saito et 
al., 2007). OHDA specificity for SNpc neurons is conferred by its affinity for dopamine 
(catecholamine) transporters (Marek et al., 1990). Dopamine, a structural analogue of 
OHDA, can also auto-oxidise to form quiniones and semiquinones with the concomitant 
production of superoxide radicals, hydrogen peroxide and hydroxyl radicals (Smythies 
and Galzigna, 1998). 
1.1.3.2 Mitochondrial dysfunction 
The role of mitochondrial dysfunction in PD pathogenesis gained attention when the 
Parkinsonian neurotoxin MPP+ was discovered to block the mitochondrial electron 
transport chain I (Cleeter et al., 1992). Subsequent studies have shown defective 
mitochondrial complex I function in some PD patients (Schapira et al., 1990; Parker et 
al., 2008). Inhibition of complex I results in a release of superoxide radicals (Kussmaul 
and Hirst, 2006). Persistent complex I inhibition can also lead to energy deficiency that 
may trigger neuronal cell death (Fonk and Baudry, 2001; Schapira, 2003).  
1.1.3.3 Proteotoxic stress 
Protein quality control is tightly linked to cellular longevity (Morimoto et al., 2011). 
The cell develops a network of interactions that maintain proper folding of proteins and 
the clearance of misfolded and damaged proteins. Proteotoxic stress occurs when cells 
abnormally build up misfolded proteins due to impairment of molecular chaperone 
systems or inhibition of protein turnover systems e.g. proteasome and autophagy 
(Morimoto, 2008). Accumulation of misfolded proteins has been associated with 
numerous neurodegenerative diseases (Ross and Poirier, 2004; Morimoto, 2008). In PD, 
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brain tissues that undergo progressive degeneration contain LB, protein deposits 
composed of alpha-synuclein fibrils, various ubiquitinated proteins, and neurofilaments 
(Gibbs and Lees, 1988). Aggregated proteins can interfere with numerous cellular 
processes including intracellular trafficking and proteasomal degradation (Bence et al., 
2001; Soper et al., 2011). Protein deposits can also adsorb many other proteins that are 
required for cell survival (Pasinelli et al., 2004). These deleterious effects contribute to 
the cytotoxic properties of protein aggregates (Bence et al., 2001; Pasinelli et al., 2004; 
Soper et al., 2011). 
1.1.4 Causative agents and risks factors 
1.1.4.1 Exposure to agricultural chemicals 
Recent meta-analyses of data from cohort and case-control studies concluded that 
occupational exposure to pesticides paraquat and maneb increases the risk of developing 
PD by about 2-fold (Pezolli and Cerada, 2013). 
Paraquat is a herbicide with a chemical structure analogous to MPP+ (Dauer and 
Przedborski, 2003). Although paraquat does not easily cross the blood brain barrier, its 
systemic administration in mice leads to degeneration of SNpc dopaminergic neurons 
and formation of α-synuclein positive inclusions (Shimizi et al., 2001; Manning-Bog et 
al., 2002; McCormack et al., 2002;). The neurotoxicity of paraquat may be attributed to 
its ability to generate superoxide radicals via its redox cycling with NADPH or NADH 
(Bus and Gibson, 1984; Hirai et al., 1992). Due to its similarity with MPP+, paraquat 
has been hypothesised to inhibit mitochondrial complex I (Fukushima et al., 1993; 
Tawara et al., 1996). 
Maneb or manganese ethylenebisdithiocarbamate is a fungicide used on agricultural 
crops. Maneb has been shown to potentiate the neurotoxicity of MPTP and paraquat 
(Takahasi et al., 1989; Thiruchelvam, 2000) and, by itself, can induce parkinsonism 
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(Meco et al., 1994). The metal and organic components of maneb contribute to its 
neurotoxicity, mainly due to mitochondrial dysfunction (Dominico et al., 2006). 
Oxidative stress has also been implicated in maneb’s toxicity because overexpression of 
SOD1 in mice protects against development of a parkinsonian phenotype induced by 
maneb (Thiruchelvam et al., 2005). 
1.1.4.2 Exposure to metals 
Epidemiological studies suggest that chronic exposure to heavy metals such as 
manganese, copper, lead, iron, mercury, and aluminium is a risk factor for developing 
PD (Gorell et al., 1997; Willis et al., 2010). In 1997, Gorell et al. conducted a 
population-based case-control study to assess the role of occupational exposure to heavy 
metals in developing PD. Their study found that people with more than 20 years of 
exposure to copper or manganese have greater association with PD. Moreover, 
individuals exposed to combinations of metals such as lead-copper, lead-iron, or iron-
copper have increased risk over those exposed to a single metal. A more recent study by 
Willis et al. (2010) supports a role for environmental exposure to copper and 
manganese in developing PD. The authors analysed the incidence of PD in US urban 
areas with various levels of industrial release of metals. They found that counties with 
high cumulative release of manganese or copper have greater incidence of PD. 
Heavy metals could be neurotoxic through various mechanisms. Copper and iron can 
catalyse redox reactions that can generate deleterious levels of reactive oxygen species 
(Kohen and Chevion, 1985). Heavy metals e.g. copper and mercury can also trigger 
protein aggregation and misfolding (Paik et al., 1999; Yang et al., 2010). Aluminum, 
copper, iron and manganese have been shown to accelerate the aggregation of alpha-
synuclein, with aluminium being the most effective metal species (Uversky et al., 2001). 
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1.1.4.3 Genetics 
Although the majority of PD cases are idiopathic in nature, monogenic PD forms with 
Mendelian inheritance account for 5-10% of the cases (Lesage and Brice, 2006). 
Familial PD shares common features with idiopathic PD including degeneration of 
SNpc dopaminergic neurons leading to motor deficits (Hardy et al., 2006). Thus far, at 
least 16 loci have been associated with familial PD (reviewed by Corti et al., 2011).  
Autosomal dominant forms of PD are caused by mutations in the genes encoding α-
synuclein and the leucine-rich repeat kinase 2 (LRRK2) (Polymeropoulos et al., 1997; 
Zimprich et al., 2004). In the case of α-synuclein, duplication or triplication of the gene 
is more common than missense mutations, accounting for 2% of all monogenic forms of 
PD (Eriksen et al., 2005; Corti et al., 2011). α-Synuclein represents a direct link 
between genetic and sporadic forms of PD as it is found as the major component of LB 
(Spillantini et al., 1997). Consistently, mutations in α-synuclein or its augmented 
expression accelerate its tendency to form LB-associated aggregates (Conway et al., 
1998; Eriksen et al., 2005). The biological function of α-synuclein remains largely 
unknown. Recent evidence suggests a role for α-synuclein in synaptic plasticity and 
neurotransmitter release, processes important for neuronal function (Burre et al., 2010; 
Bendor et al., 2013).  Amongst the causative genes, LRRK2 (PARK8) mutations are the 
most prevalent (Lesage and Brice, 2006). LRRK2 encodes a 286-kDa multidomain 
protein with kinase, GTPase, and protein scaffolding activities (Mata et al., 2006). 
Mutation hotspots include the Ras of complex protein (Roc) GTPase domain and the 
tyrosine-link kinase (TKL) domain (Corti et al., 2011). LRRK2’s cellular function is 
associated with protein translation control, apoptosis, mitogen-activated protein kinase 
pathways, and cytoskeleton dynamics (reviewed by Webber and West, 2009).  
Four genetic loci for autosomal recessive forms of PD have also been mapped. Three 
loci are found on chromosome 1, namely PINK1 (PARK6) (Valente et al., 2003), DJ-1 
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(PARK7) (Bonifati et al., 2003), and ATP13A2 (PARK9) (Ramirez et al., 2006) while 
chromosome 6 contains PARKIN (PARK2) (Lucking et al., 2000). Mutations in these 
genes lead to early-onset parkinsonism. Parkin, an E3 ubiquitin ligase, targets a set of 
protein substrates for degradation (Haas and Kahle, 2001). Parkin is also involved in the 
removal of damaged mitochondria via a process called mitophagy (Narendra et al., 
2009). PINK1 (PTEN-induced kinase 1) is a Ser/Thr kinase targeted to the mitochondria 
(Valente et al., 2003). Recently, PINK1 has been shown to phosphorylate the Ubl 
domain of Parkin which in turn activates Parkin’s E3 ubiquitin ligase activity, 
demonstrating an interplay between genes involved in familial PD (Vives-Bauza et al., 
2010; Kondapalli et al., 2012; Iguchi et al., 2013).  ATP13A2 is a cation-transporting 
ATPase that localises to endosomal and lysosomal membranes (Ramirez et al., 2006). 
Deregulation of cation homeostasis and lysosomal dysfunction have been associated 
with ATP13A2 mutational inactivation (Schneider et al., 2010; Ramonet et al., 2012; 
Rochet, 2012).  
In 2003, Bonifati et al. identified mutations in DJ-1 that are linked to autosomal 
recessive juvenile PD. Subsequent studies identified more sequence variants of DJ-1 
that are associated with PD development (Abou-Sleiman et al., 2003; Hague et al., 2003; 
Clark et al., 2004; Djarmati et al., 2004; Hering et al., 2004; Anessi et al., 2005; Tang et 
al., 2006). DJ-1 is a pleiotropic gene associated with numerous biological processes. A 
comprehensive introduction to DJ-1 will be presented in the next section. 
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1.2 Introduction to DJ-1 
 
1.2.1 The DJ-1 gene and its product 
The DJ-1 gene has been mapped to chromosome 1p36.2-p36.3 (Figure 2; Taira et al., 
2001; Bonifati et al., 2003). It is composed of 8 exons spanning 24 kbp, with exons 1A 
and 1B being non-coding and alternatively spliced (Bonifati et al., 2003). DJ-1 
expression is controlled by an Sp1 promoter (Taira et al., 2001). The brain expresses 
DJ-1, with greater distribution in the subcortical regions e.g. hippocampus, thalamus, 
caudate nucleus and substantia nigra, the region affected in PD (Olzmann et al., 2007).  
DJ-1 encodes an ~19 kDa polypeptide that resides in the cytoplasm and the nucleus 
(Bonifati et al., 2003); mitochondrial localisation may be triggered by oxidative stress 
(Canet-Aviles et al., 2004). The structure of DJ-1 adopts a flavodoxin-like α/β fold 
composed of a 6-stranded β-sheet core sandwiched by 8 α-helices (Figure 3; Honbou et 
al., 2003; Huai et al., 2003; Lee et al., 2003; Tao and Tong, 2003; Wilson et al., 2003). 
Two protomers interact to form a homodimer (Figure 4). Mutations that disrupt 
homodimerization abrogate the antioxidant activity of DJ-1, hence highlighting the 
physiological role of the homodimeric state in the cellular function of DJ-1 (Taira et al., 
2004). The protein shares homology with the Pyrococcus horikoshii cysteine protease 
PfpI (30% identity), the Escherichia coli thiamine biosynthetic enzyme ThiJ (41% 
identity) and the E. coli molecular chaperone YajL (41% identity). 
One of the structural features of DJ-1 is the nucleophile elbow identified by the 
consensus sequence Sm-X-Nu-X-Sm where Sm = a small residue (i.e. a residue with a 
side chain that spans less 5 Å such as Ala or Gly), Nu = nucleophile, and X = any 
residue (Nardini and Dijkstra, 1999). This motif uniquely positions the nucleophilic 
residue (Cys-106 in case of human DJ-1) in a tight turn of a strand-helix transition, 
specifically β7-loop-α5. This motif is important for a number of reported DJ-1 
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biochemical activities including its glyoxalase activity (Lee et al., 2012) and weak 
proteolytic activity (Olzmann et al., 2004). 
 
Figure 2. Chromosome location and gene structure of DJ-1. The DJ-1/PARK7 locus 
is mapped to chromosome 1p36.2-p36.3. The 24-kbp gene is composed of 8 exons with 
exons 1A and 1B being non-coding and alternatively spliced. Chromosome 1 map was 
derived from www.genecards.com. 
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 Figure 3. Protein sequence and structure of DJ-1. DJ-1 is a 189-amino acid 
polypeptide that adopts a flavodoxin-like fold composed of a six-stranded β-sheet core 
sandwiched by 8 α-helices. A cartoon representation of the DJ-1 structure (PDB ID 
code: 1PDV) rendered using PyMol (Delano, 2002) is depicted in the top panel with 
rainbow colouring to show the sequential arrangement of residues. The lower panel, 
obtained from PDBsum (www.ebi.ac.uk/pdbsum), shows the annotated amino acid 
sequence of DJ-1 with superimposition of the secondary structure.  represents an 
α-helix,  represents a β-strand, and  represents a β-turn. 
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1.2.2 DJ-1 and  PD 
DJ-1 or PARK7 is the third locus to be discovered for autosomal recessive juvenile 
parkinsonism, after PARKIN (PARK2) and PINK1 (PARK6) (Bonifati et al., 2003). 
Similar to mutations in PARKIN and PINK1, the phenotype of patients with DJ-1 
mutations manifest the classical clinical symptoms e.g. postural tremor, bradykinesia 
with an asymmetric onset before the age of 40. Psychiatric symptoms including anxiety 
and psychotic episodes have also been documented in affected patients (Abou-Sleiman 
et al., 2003; Bonifati et al., 2003).  
To date, there has been no pathology report on patients affected with a DJ-1 mutation. 
However, studies using transcranial ultrasound have demonstrated hyperechogenicity in 
the substantia nigra, a neuropathological feature of PD (Schweitzer et al., 2007). 
Positron Emission Tomography (PET) neuroimaging also revealed significant depletion 
of dopamine in the patient’s brain (Dekker et al., 2004). 
Structural and biochemical characterisations of disease-linked sequence variants of DJ-1 
have provided insights into the molecular mechanisms by which mutations lead to loss 
of DJ-1 function. The positions of the mutations in the structure of DJ-1 are depicted in 
Figure 5. Most PD-linked mutations e.g. L166P, L10P, L158del in DJ-1 are found to 
destabilise the structure of DJ-1 leading to a rapid clearance of the protein inside the cell 
(Moore et al., 2003; Gorner et al., 2004; Olzmann et al., 2004; Blackinton et al., 2005; 
Ramsey and Giasson, 2010; Rannikko et al., 2012). Some mutations (L166P, L10P, 
P158del, M26I, E163K, A104T, D149A) decreases the ability of DJ-1 form 
homodimers implicating the crucial role of the dimeric state in DJ-1 function (Moore et 
al., 2003; Taira et al., 2004; Takahashi-Niki et al., 2004; Moore et al., 2005; Hulleman 
et al., 2007, Lakshminarasimhan et al., 2007; Repici et al., 2013). More subtle 
mutations (E64D, A179T) have also been linked to PD that do not show an apparent 
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change in the structural stability or dimerisation of the protein (Gorner et al., 2004; 
Rannikko et al., 2012; Repici et al., 2013).  
 
Figure 4. Structure of DJ-1 homodimer and the locations of PD-linked mutations. 
A cartoon representation of the DJ-1 homodimer (PDB ID code: 2OR3) with the side 
chains of residues individually mutated in PD shown as red spheres in one protomer. 
Structure was rendered using PyMol (Delano, 2002). 
1.2.3 Biological activities of DJ-1 
1.2.3.1 Peroxiredoxin-like peroxidase 
The function of DJ-1 is closely associated with cellular protection against oxidative 
stress. Several groups have shown that DJ-1 knockdown sensitises cells to substances 
that induce oxidative stress such as H2O2 (Taira et al., 2004), dopamine (Lev et al., 2009) 
and PD toxins MPTP (Kim et al., 2005; Aleyasin et al., 2010), paraquat (Yang et al., 
2007) and OHDA (Sun et al., 2012; Lev et al., 2013). 
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The exact mechanism by which DJ-1 exerts its antioxidant effects remains elusive. 
Andres-Mateos et al. (2007) proposed that the antioxidant effect of DJ-1 is based on an 
atypical peroxiredoxin-like peroxidase activity whereby the highly conserved Cys-106 
is critical for the detoxification reaction. Peroxiredoxins are enzymes that eliminate 
H2O2 and organic peroxides via redox cycling of cysteine residues (Wood et al., 2003). 
Reaction of a peroxidatic cysteine with peroxides results in oxidation of the thiol moiety 
(-SH) into a sulphenic acid (-SOH) that is usually resolved to a disulphide linkage by 
another cysteine and/or reduced by an endogenous reducing agent (Figure 5A and 5B; 
Wood et al., 2003). In contrast, the atypical peroxidatic cysteine in DJ-1, Cys-106, is 
converted to a sulphinic acid (-SOOH) that cannot be reduced by endogenous reductants 
or by sulfiredoxin, an ATP-dependent enzyme that catalyses the reduction of sulphinic 
acid (Figure 5C; Woo et al., 2005). Therefore, the oxidation of Cys-106 to a cysteine 
sulphinic acid is irreversible and hence not capable of multiple turnover reactions 
challenging the notion that DJ-1 plays a major role in directly eliminating reactive 
peroxide species. Rather, the facile oxidation of DJ-1 Cys-106 has been considered to 
be a modification that influences its biological activities (Wilson, 2010).  
1.2.3.2 Transcriptional regulation 
Deficiency in DJ-1 has been shown to alter the mRNA expression levels of a number of 
proteins including the glutamate cysteine ligase (Zhou and Freed, 2005), superoxide 
dismutase 3 (Nishinaga et al., 2005), bax (Bretaud et al., 2007; Fan et al., 2008), 
tyrosine hydroxylase (Ishikawa et al., 2010), thioredoxin 1 (Im et al., 2012), p21 and 
dual specificity phosphatase 1 or DUSP1 (Kato et al., 2013). 
One of the ways by which DJ-1 regulates transcription is through its inhibitory 
interaction with the negative regulators of transcription factors. The androgen receptor 
(AR) was the first transcription factor shown to be regulated by DJ-1 (Takahashi et al., 
2001). DJ-1 restores AR activity that is repressed by negative regulators protein 
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inhibitor of activated STAT x isoform  alpha (PIASxα) and DJ-1 binding protein (DJBP) 
(Takahashi et al., 2001; Niki et al., 2003). DJ-1 is found to directly interact with the AR 
binding site of PIASxα thereby preventing its interaction with AR (Takahashi et al., 
2001). DJ-1 also interacts with DJBP, a scaffold protein that recruits the histone 
deacetylase complex (HDAC) to inhibit AR activity (Niki et al., 2003). DJ-1 blocks the 
recruitment of HDAC to AR by binding the HDAC interaction site of DJBP (Niki et al., 
2003). 
 
Figure 5. Enzymatic mechanism of peroxiredoxins. (A) 2-Cys peroxiredoxins 
detoxify hydrogen peroxide by oxidising the thiol moiety of the peroxidatic cysteine to 
a sulphenic acid. An adjacent cysteinyl residue resolves the sulphenic acid moiety by 
forming a disulphide bond with the peroxidatic cysteine. Finally, a thiol-based reductant 
(RSH) restores the thiol moieties. (B) In 1-Cys peroxiredoxins, the sulphenic acid is 
directly reduced by an endogenous RSH. (C) Oxidation of DJ-1 Cys-106 results in the 
irrerversible formation of a cysteine sulphinic acid that cannot be reduced by a 
sulfiredoxin (Srx) or RSH. 
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DJ-1 can also directly interact with transcription factors such as p53 (Fan et al., 2008; 
Kato et al., 2013). The p53-dependent upregulation of bax expression observed after 
DJ-1 knockdown in zebrafish suggested a functional interaction between DJ-1 and p53 
(Bretaud et al., 2007). Later in vitro studies have shown a physical interaction between 
DJ-1 and the DNA-binding and C-terminal domains of p53 (Fan et al., 2008; Kato et al., 
2013). Binding of DJ-1 to p53 selectively inhibits p53 transactivation based on 
promoter affinity (Kato et al., 2013).  
Tyrosine hydroxyalse (TH) is required for dopamine synthesis and thus is highly 
expressed in dopaminergic neurons of the substantia nigra (Nagatsu et al., 1964). TH 
expression is also regulated by DJ-1 in a species specific manner (Ishikawa et al., 2010). 
DJ-1 controls TH expression by inhibiting the conjugation of small ubiquitin-like 
modifier 1 (SUMO-1) to Pyrimidine tract-binding protein-associated splicing factor or 
PSF (Zhong et al., 2006). SUMOylated PSF recruits HDAC to repress the transcription 
of the TH promoter. Interestingly, DJ-1 also suppresses PSF SUMOylation to activate 
the peroxisome proliferator-activated receptor γ coactivator 1 alpha (PGC-1α), a master 
regulator of mitochondrial biogenesis and stress response (Zhong and Xu, 2008). 
1.2.3.3 Molecular chaperone 
Molecular chaperones assist polypeptides to fold correctly and maintain their structural 
stability. D-1 has been reported to act as a molecular chaperone that is capable of 
preventing heat-induced aggregation of classic chaperone substrates citrate synthase and 
luciferase (Lee et al., 2003; Shendelman et al., 2004). Interestingly, two groups have 
shown that DJ-1 prevents the formation of α-synuclein aggregates in vitro and in vivo 
(Shendelman et al., 2004; Zhou et al., 2006). Both groups reported a redox state 
dependent chaperone activity whereby oxidation of a cysteine residue during oxidative 
stress activates the chaperone activity. Shendelman et al. (2004) have implicated Cys-53 
as the critical residue for the chaperone activity however Zhou et al. (2006) have shown 
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that Cys-106 is the highly oxidisable residue that senses oxidative stress and is required 
for the chaperone activity. 
1.2.3.4 RNA binding  
In 2008, van der Brug et al. used four different methods to show that DJ-1 directly 
binds mRNA of genes associated with the mitochondria, glutathione metabolism, and 
effectors of PTEN/PI3K pathway. DJ-1 interacts with the GG/CC rich sequences of 5’ 
and 3’ untranslated regions of the mRNA. Binding of DJ-1 to an mRNA partially 
suppresses translation. During oxidative stress, mRNAs dissociate from DJ-1 thereby 
relieving translational inhibition. mRNA dissociation is determined by the oxidation 
state of DJ-1 albeit no information on which residues sense oxidative stress was 
reported. 
1.2.3.5 Weak protease activity 
The structural homology between DJ-1 and the prokaryotic protease PfpI suggested the 
possibility of DJ-1 acting as a protease. A putative catalytic triad involving Glu-18, 
Cys-106, and His-126 is suggested by the crystal structures of DJ-1 (Honbou et al., 
2003; Huai et al., 2003; Lee et al., 2003; Tao and Tong, 2003; Wilson et al., 2003). Lee 
et al. (2003) noted the presence of a C-terminal α9 that blocks the catalytic site hence 
the lack of an apparent proteolytic activity of DJ-1. However, Olzmann et al. (2004) 
detected an intrinsic protease activity for casein using a highly sensitive fluorescence-
based assay although about 6000-fold less efficient than trypsin.  Subsequently, Chen et 
al. (2010) reported that mild oxidative stress results in the cleavage of the occluding C-
terminal helix thereby exposing a protease catalytic dyad involving His-126 and the 
nucleophile Cys-106. Recently, the protease activity of DJ-1 was found to target the 
consensus sequences Val-Lys-Val-Ala (VK↓VA) (Mitsugi et al., 2013).  
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1.2.3.6 Copper binding and activation of SOD1 
The Cu-Zn superoxide dismutase (SOD1) is a homodimeric metalloenzyme essential for 
antioxidant defence against highly reactive superoxide radicals (Figure 6A). A copper 
cofactor in the active site, held by His-46, His-48, His-63, and His-120, is required for 
catalysis while a zinc ion plays a structural role (Figure 6B). SOD1 exploits the redox 
properties of copper to facilitate the conversion of superoxide radicals into hydrogen 
peroxide and oxygen.  
 
Figure 6. Cu-Zn superoxide dismutase. (A) Cartoon representation of the structure of 
the holo-SOD1 dimer (PDB ID code: 2C9V). Structure was rendered using PyMol 
(Delano, 2002). (B) The SOD1 active site with the copper ion (orange sphere) 
coordinated by His-46, His-48, His-63, and His-120. The zinc ion (grey sphere) is held 
by His-71, His-80, and Asp-82. (C) SOD1 catalyses the disproportionation of 
superoxide using a copper cofactor. DJ-1 has been proposed to provide the copper 
cofactor to SOD1 (Xu et al., 2010). 
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An interaction between DJ-1 and SOD1 has been demonstrated (Xu et al., 2010; 
Yamashita et al., 2010; Knobbe et al., 2012). Xu et al. (2010) have shown that DJ-1 not 
only interacts with SOD1 but also binds copper (as CuSO4). They have further shown 
that DJ-1, when expressed recombinantly in the presence of copper, is capable of 
stimulating the activity of SOD1, suggesting a role for DJ-1 in providing the copper 
cofactor of SOD1 (Figure 6C). The activation of SOD1 by DJ-1 reveals a mechanism by 
which DJ-1 could potentially protect cells against oxidative stress. However, the 
molecular basis for this copper chaperone activity is lacking. 
Recently, Bjorkblom et al. (2013) confirmed the ability of DJ-1 to sequester copper and 
mercury, a structural surrogate for copper. They have further shown that DJ-1 
overexpression in dopaminergic neuroblastoma cells conferred protection from copper- 
and mercury-induced cytoxicity. This protection was lost in PD-linked sequence 
variants (A104T, D149A) of DJ-1 that reduces DJ-1 homodimerisation. How DJ-1 
sequesters free copper ions to prevent their nonspecific damaging reactions in the cell 
remains uncharacterised. 
1.2.3.7 Cofactor-independent glyoxalase 
α-Oxoaldehydes e.g. methylglyoxal (MGO) and glyoxal (GO) are ubiquitous products 
of cellular metabolism. MGO and GO are highly reactive dicarbonyl species generated 
by spontaneous breakdown of triose phosphates (Phillips and Thornalley, 1993), 
nonenzymatic protein glycation (Thornalley et al., 1999), glucose oxidative degradation 
(Wells-Knecth et al., 1995), and enzymatic oxidation of aminoacetone and ketone 
bodies (Cazassa et al., 1984; Aleksandrovskii, 1992; Lyles and Chalmers, 1992). MGO 
and GO are strong electrophiles that can react with lysine, arginine, and histidine 
residues of proteins, producing adducts belonging to a class of irreversible 
modifications called advanced glycation end products (AGEs; Thornalley et al., 1999). 
For instance, lysines react with GO and MGO to produce carboxymethylysine (CML) 
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and carboxyethyllysine (CEL), respectively (Figure 7). MGO- and GO-induced 
modifications can lead to aggregation and functional inactivation of proteins (Assero et 
al., 2001; Morgan et al., 2002; Shaikh and Nicholson, 2008). MGO and GO can also 
target DNA resulting in strand breakage and interstrand crosslinking (Rahman et al., 
1990). Whilst oxidation can generate α-oxoaldehydes, MGO and GO are also capable of 
producing ROS (Ramasamy et al., 2005; Ramasamy et al., 2006; Kuntz et al., 2010), 
feeding a vicious cycle of ROS- α-oxoaldehyde production.  
 
Figure 7. GO and MGO modifications of lysine residues lead to formation of AGEs. 
Endogenously produced GO and MGO can directly react with the free amine group of 
lysine to form CML and CEL, respectively. 
To prevent the accumulation of cytotoxic levels of MGO and GO, cells employ a 
glutathione-dependent glyoxalase enzyme system composed of two distinct enzymes 
glyoxalase I (GLO1) and glyoxalase II (GLO2) that act together to inactivate α-
oxoaldehydes (Thornalley, 1990). The substrate for GLO1 is a hemithioacetal formed 
by the reaction of glutathione with the α-oxoaldehydes (Thornalley, 2003). GLO1 
converts the hemithioacetal substrate into S-(D)-lactosylglutathione that feeds into 
GLO2 for the hydrolytic removal of glutathione and the release of D-lactate (Thornalley, 
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1990; Cameron et al., 1999; Thornalley, 2003). Figure 8A summarises the enzymatic 
breakdown of methylglyoxal by GLO1 and GLO2. 
A glutathione-independent glyoxalase system was first identified in prokaryotes (Misra 
et al., 1995). In E. coli, Hsp31 has been identified as a glyoxalase capable of catalysing 
the conversion of methylglyoxal into D-lactate in the absence of any cofactor (Figure 
8B; Subedi et al., 2011). Hsp31 is homologous to human DJ-1. Lee et al. (2012) 
demonstrated a glyoxalase activity for DJ-1 that does not require a gluthathione cofactor, 
hence, insofar represents the only eukaryal cofactor-independent glyoxalase. DJ-1 
converts GO and MGO into glycolic acid and lactic acid, respectively (Figure 8C). By 
acting as a glyoxalase, DJ-1 can protect cells from cellular degeneration induced by 
toxic accumulation of GO and MGO. 
A reaction mechanism for the DJ-1 glyoxalase activity using methylglyoxal as a 
substrate was proposed based on the catalytic mechanisms of GLO1 and GLO2 (Figure 
9; Kwon et al., 2013). The initial step involves the nucleophilic attack on the aldehydic 
carbonyl carbon  (C1) of methylglyoxal by the S-thiolate of Cys-106, forming a 
hemithioacetal intermediate. The next step involves a general acid-base catalysis 
whereby Glu-18 abstracts a proton from C1, forming an enediol intermediate, followed 
the ketonisation of C1 to form an S-lactoylcysteine. Finally, the lactic acid product is 
produced through hydrolysis of the thioester. 
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Figure 8. Glyoxalase reactions of GLO1/GLO2, Hsp31, and DJ-1. (A) The 
GLO1/GLO2 system catalyses the conversion of a glutathione (GSH) adduct of 
methylglyoxal into D-lactic acid. (B) In contrast, the E. coli Hsp31 is capable of 
converting methylglyoxal into D-lactic acid in the absence of any cofactor. (C) 
Likewise, DJ-1 possesses a cofactor-independent glyoxalase activity that detoxifies 
MGO and GO into lactic acid and glycolic acid, respectively. 
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Figure 9. Proposed reaction mechanism for DJ-1 glyoxalase activity (adapted from 
Kwon et al., 2013). 
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1.3 Aims 
Although the ability of DJ-1 to sequester copper has been reported, the molecular means 
through which DJ-1 carries out this function is unknown. The first part of this 
dissertation aims to determine the structural and biochemical bases of the interaction of 
DJ-1 with copper, in order to provide insights into how PD-linked mutations would 
perturb this function. Specifically, the project attempted to achieve the following: 
1. Define the chemical features and stoichiometry of the protein-metal complex 
using solution spectroscopy and mass spectrometry 
2. Map the copper binding site using X-ray crystallography. 
3. Determine the affinity of DJ-1 for copper to confirm the physiological formation 
of the complex. 
4. Test the ability of DJ-1 to provide copper for SOD1. 
The second part of this dissertation aims to characterise the structural and functional 
consequences of DJ-1 A107P mutation associated with early-onset Parkinson’s disease. 
The mutation occurs in the nucleophile elbow motif of DJ-1, adjacent to a conserved 
cysteinyl residue that is critical for a number of DJ-1 cellular functions. This project 
aimed to achieve the following: 
1. Produce a recombinant form of DJ-1 with the A107P mutation. 
2. Determine the ability of the A107P variant to detoxify glyoxal. 
3. Define the role of Ala-107 in the catalytic mechanism of DJ-1 glyoxalase 
activity using in silico and crystallographic analyses. 
4. Determine the intracellular steady-state level of the A107P variant. 
5. Characterise the structural changes caused by the A107P mutation using CD and 
NMR spectroscopy. 
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Chapter 2 
Structural basis for the interaction of DJ-1 with Cu(I) 
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2.1 Introduction 
Copper is an essential cofactor in several biological processes, however paradoxically, 
its mishandling may result in reactions that can lead to cellular damage. To prevent this 
deleterious effect, the eukaryotic cell limits the intracellular level of free copper ions 
down to a negligible concentration (Rae et al., 1999). This poses a challenge for copper-
binding proteins and a clear requirement for copper chaperones that can acquire and 
ferry copper ions to a target protein. SOD1 is a copper-requiring enzyme that converts 
the superoxide radical into less active products, hydrogen peroxide and oxygen 
(McCord and Fridovich, 1969). The 27-kDa protein CCS (Copper Chaperone for 
Superoxide dismutase) is mainly responsible for the copper acquisition and activation of 
SOD1 (Culotta, 1997). CCS has three domains; domains I and III are responsible for 
copper binding and transfer while domain II is required for interaction with SOD1 
(Figure 11; Schmidt et al., 1999; Rae et al., 2001). The copper ions are held through 
metal binding sites identified by the consensus sequence CXXC or CXC where C is a 
cysteinyl residue and X is any residue (Figure 10; Schmidt et al., 1999; Rae et al., 2001). 
An alternative pathway for copper acquisition by SOD1 is known to exist as a mouse 
CCS knockout retained ~15% of brain SOD1 activity (Wong et al., 2000). The factors 
contributing to this alternative pathway remain elusive. In 2010, Xu et al. demonstrated 
the ability of DJ-1 to bind copper and stimulate the activity of SOD1. Their results 
suggest a copper chaperone function for DJ-1 that potentially plays a role in the 
alternative pathway.  
More recently, Bjorkblom et al. (2013) also demonstrated the ability of DJ-1 to 
sequester metals such as copper and mercury and protect cells from metal-induced 
cytotoxicity. DJ-1 has neither a metal binding sequence motif (CXXC or CXC) nor a 
CCS SOD-like domain that can interact with SOD1. Hence, the structural and chemical 
means by which DJ-1 carries out either a copper chaperone activity or metal 
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sequestration is not understood. In this chapter, the molecular basis of the interaction of 
DJ-1 with copper was characterised using spectroscopic analysis, mass spectrometry 
and X-ray crystallography coupled with structure-guided mutational analysis. 
 
 
 
Figure 10. Crystal structure of the yeast CCS. Cartoon representation of the yeast 
copper chaperone for SOD1 (PDB ID code: IQUP). Domains I, II and III are coloured 
blue, magenta and yellow, respectively. The lower panel depicts the metal binding 
sequence motifs CXXC and CXC in domains I and III, respectively. Structures were 
rendered using PyMol (Delano, 2002). 
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2.2 Results 
2.2.1 Recombinant protein expression and purification of human DJ-1 
To produce proteins for structural and biochemical analysis, DJ-1 was cloned in a 
bacterial expression vector pET-28a. A DJ-1 construct with a C-terminal hexahistidine 
(His6) tag was prepared to allow high-yield expression of DJ-1 that could be easily 
purified by Ni
2
/Co
2+
-affinity chromatography. This construct is identical to the once 
used by Liang and Tong (2003) to produce diffracting crystals of DJ-1 and hence was 
used to set up crystal screens. An untagged DJ-1 construct was also prepared for 
biochemical assays to prevent fortuitous interaction of copper with the His6 tag.  
 
Figure 11. SDS-PAGE analysis of purified DJ-1. Proteins were expressed in E. coli 
BL21(DE3) cells, transformed with the appropriate pET-28a DJ-1 construct. A protein 
extract was prepared from the cells and was fractionated using Co
2+
-affinity resin 
(Pierce) for His6 tagged protein or phenyl sepharose for untagged DJ-1 protein and 
finally passed through Q-sepharose resin. An aliquot of the final eluate was analysed by 
SDS-PAGE using a 12% w/v acrylamide gel stained with Coomassie R-250. (A) His6 
tagged DJ-1. Lane 1: Pierce PageRuler prestained molecular weight marker, indicated 
sizes in kDa; lane 2: Purified His6 tagged DJ-1. (B) Untagged DJ-1. Lane 1: Pierce 
unstained molecular weight marker, indicated sizes in kDa; lane 2: Purified untagged 
DJ-1.  
46 
 
The recombinant His6-tagged DJ-1 protein was expressed as a soluble protein with good 
yield, about 15 mg of purified protein was obtained per litre of culture,  using E. coli 
BL21 (DE3). The protein was purified as a single band after Co
2+
-affinity and Q-
sepharose chromatography with an apparent molecular weight of 25 kDa (Figure 11A). 
The theoretical molecular weight is 20956 Da for the His-tagged DJ-1 monomer.  
Untagged DJ-1 was expressed in E. coli BL21 (DE3) following the same conditions 
used for His6-tagged DJ-1. The initial ammonium sulphate (60% saturation) cut 
precipitated the majority of E. coli proteins while keeping DJ-1 soluble. Phenyl-
sepharose chromatography successfully isolated pure DJ-1 which was eluted using 40% 
ammonium sulphate saturated buffer. Wild-type DJ-1 did not bind the Q-sepharose 
resin and eluted as a 25-kDa band (Figure 11B). The theoretical molecular weight of 
untagged DJ-1 is 19891 Da. The band at 50 kDa corresponds to a DJ-1 homodimer 
which is occasionally observed when the purified protein has not been thoroughly 
denatured. Fifteen milligrams of untagged protein was obtained per litre of culture 
2.2.2 Electronic absorption spectroscopy indicates that Cu(I) is coordinated 
through thiolate Sγ. 
Using isothermal calorimetry, Xu et al. (2010) have shown that DJ-1 can bind Cu(II). 
But inside the cell, Cu(I) is the predominant oxidation state of copper and the form 
delivered by metallochaperones (Davis and O’Halloran, 2008). Therefore I chose to 
characterise the interaction of untagged DJ-1 with Cu(I). Since Cu(I) is easily oxidised 
in the presence of oxygen, the experiments were performed in an anaerobic box under a 
N2 atmosphere. A solution of [Cu(CH3CN)4]PF6 was chosen as a Cu(I) source. 
Interaction of metals with proteins can be monitored by electronic absorption 
spectroscopy (Boal and Resenzweig, 2009). The charge transfer transition between the 
metal and the ligating residues results in the absorption of a quantum of energy that is 
indicative of a specific metal coordinating complex (Que, 2000). The electronic 
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absorption spectrum of the Cu(I)-titrated DJ-1 displayed an absorption band centered at 
254 nm (Figure 12), a common spectral feature of metallochaperones that bind Cu(I) via 
thiolate moieties of cysteinyl residues (Cobine et al., 2000). This absorbance peak 
specifically results from a charge transfer transition between an Sγ atom of a thiolate 
group and a Cu(I) ion (Cobine et al., 2000). There were no peaks observed around 500-
600 nm which corresponds to the interaction of copper ions with histidine residues 
(Cobine et al., 2000). This indicates that the copper ion is specifically coordinated by 
cysteinyl residues.  The spectrum of as-isolated DJ-1 did not show the absorption band 
at 254 nm suggesting that the recombinant DJ-1 might have lost the copper during the 
purification procedure. 
 
 
Figure 12. Absorption spectrum of Cu(I)-titrated DJ-1. Addition of a stoichiometric 
amount of Cu(I) to untagged DJ-1 solution (10 µM dimer, orange line) under anaerobic 
conditions resulted in the development of an absorption band around 254 nm indicating 
the formation of a complex between a thiol sulphur and Cu(I). Copper-free (as-isolated) 
DJ-1 (blue line) did not show the characteristic absorption band. The spectrum of the 
Cu(I) titrant (10 µM) is shown as a black line.  
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2.2.3 DJ-1 interacts with Cu(I) as a Cu
I
(DJ-1)2 complex 
To determine the stoichiometry of the complex, DJ-1 was incubated with molar excess 
of Cu(I) stabilised with reduced glutathione (Ciriolo et al., 1990), hereafter referred to 
as Cu(I)-GSH, and subjected to matrix-assisted laser desorption ionisation time-of-flight 
(MALDI-TOF) and nanoflow electrospray ionisation mass spectrometry (nESI-MS). 
MALDI-TOF has been used to determine metal adducts of proteins, however, samples 
are more prone to denaturation and fragmentation (Hartinger, et al., 2008). nESI-MS 
has superior sensitivity with the advantage of analysing protein-protein, protein-ligand, 
and protein-metal interactions in a native state (Benesch et al., 2007). 
The mass spectrum derived from the MALDI-TOF analysis of the apo form of the 
untagged DJ-1 showed a predominant monomeric species with a centroid mass of 
19753 Da, consistent with the notion that MALDI-TOF denatures most of the protein. 
However, the molecular ion peak at m/z 39513.1 indicated the presence of a DJ-1 
homodimer (Figure 13A). When a 4-fold molar excess of fresh Cu(I)-GSH was 
incubated with DJ-1 solution prior to analysis, the molecular ion peak increased by ~67 
Da, demonstrating the formation of a copper monoadduct of the DJ-1 homodimer 
(Figure 13B). 
Subsequently, nESI-MS was used to analyse the complex in a more native state. 
Various charge states that match the molecular mass of untagged recombinant DJ-1 
were detected in the mass spectrum of the metal-free protein (Figure 14A). In contrast 
to MALDI-TOF, a dimeric species dominated the spectrum consistent with the ability of 
nESI-MS to analyse native complexes. When Cu(I)-GSH was added in 4-fold excess 
over dimeric DJ-1, a mass increase of 374 m/z was observed for the peak corresponding 
to the dimeric species, suggesting an interaction between a DJ-1 homodimer, a single 
Cu(I) ion (63 Da), and a further glutathione species (305 Da) (Figure 14B). A small 
fraction of the DJ-1 monomer showed a mass increase of 302 Da, indicating a covalent 
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glutathione adduct. However, a greater proportion of monomeric species were not 
covalently linked to glutathione suggesting the possibility of glutathione participating as 
a third ligand for Cu(I) with the dimeric species. Glutathione has been previously shown 
to act as an exogenous ligand for coordinating Cu(I) to copper chaperones with a 
biscysteinate metal binding site (Ralle et al., 2003). Such a tri-coordinate complex has 
been proposed to represent a metal-transfer mechanism involving the exchange of 
ligands between the copper chaperone and the target protein (Ralle et al., 2003). 
 
Figure 13. Cu(I) interaction of DJ-1 probed by MALDI-TOF. Panel A shows the 
mass spectrum of the apo-DJ-1. Inset shows the mass (39513.1 Da) of the molecular ion 
peak which represents DJ-1 homodimer (DJ-1)2. Panel B shows the mass spectrum of 
the apo-DJ-1 treated with 4-fold molar excess of Cu(I)-GSH prior to sampling into the 
matrix. Inset shows the centroid mass (39580.5 Da) of the molecular ion peak which 
represents the Cu(I)-bound DJ-1 homodimer. 
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Figure 14. Cu(I) interaction of DJ-1 probed by nESI-MS. Panel A shows the mass 
spectrum of apo-DJ-1; calculated  masses  19865  ±  1  Da (monomer/DJ-1; 8+ charge 
state) and 39842 ± 10 Da (homodimer/(DJ-1)2; 12+ charge state). Panel B shows the 
mass spectrum of DJ-1 incubated with Cu(I)-GSH. Inset shows the mass increase of 374 
Da of the DJ-1 homodimer ((DJ-1)2; 12+ charge state) when incubated with 4-fold 
molar excess of Cu(I)-GSH (red peak).  
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2.3.4 Crystal structure of Cu(I)-bound DJ-1 reveals a new copper binding motif 
X-ray crystallography was used to map the copper binding site. Crystals of His6-tagged 
DJ-1 were grown according to conditions described by Tao and Tong (2003). 
Hexagonal bipyramidal crystals grew overnight (Figure 15A). Crystals were soaked in 
the mother liquor containing molar excess of Cu(I)-GSH. The soaked crystals diffracted 
to 1.4 Å and were isomorphous to the apoprotein crystal with a space group P3121. An 
initial model was obtained by molecular replacement and after several cycles of 
refinement, the final structure achieved an Rwork/Rfree of 0.1184/0.1498 (see Table 2 for 
data collection and refinement statistics).  
The omit difference density map derived from the Cu(I)-soaked crystal showed that the 
Cu(I) is coordinated by the Sγ atoms of the thiolate side chains of cysteine 53 from each 
monomer forming a biscysteinate copper centre (Figure 15B and 15C). The coordinate-
covalent bond between Cu(I) and Sγ exhibits a distance of 1.9 Å. The complex has 
almost a linear molecular geometry with S-Cu-S bond angle of 163.2°. Contrary to the 
nESI-MS results, glutathione was not found to be ligated to Cu(I) in the crystal structure. 
Crystal packing may have occluded the formation of a glutathione adduct. Copper 
binding did not induce a gross change in the conformation of DJ-1 (backbone RMSD to 
the apoprotein form was within 0.2 Å, see Figure 16 for the superimposed structures). 
The copper centre is expected to have a -1 charge as a result of +1 from the metal ion 
and -1 charge from each thiolate group. Unlike other copper centres, the site is not 
neutralised by a nearby positively-charged residue e.g. lysine such as in Atox1 
(Rodriguez-Granillo and Wittung-Stafshede, 2009). The copper binding cysteine is 
succeeded by a proline residue. Such a Cys-Pro motif has been shown to maximise the 
charge neutralisation effect conferred by an α-helix macrodipole to a metal binding site 
(Changela et al., 2003). However, the Cys-Pro motif in DJ-1 is not found at the N-
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terminus of a α-helix therefore an α-helix macrodipole does not contribute to the 
neutralisation of the negative charge at the copper centre. 
To determine the oxidation state of the bound copper ion in crystallo, single crystal 
electronic absorption spectroscopy was performed in collaboration with beamline 
scientists at the Diamond Light Source, Oxford. The absorption spectrum (Figure 17A) 
recorded from the  crystal derivatised with Cu(I) showed the same absorption peak at 
254 nm of the protein solution titrated with Cu(I) (Figure 12). In addition, X-ray 
fluorescence spectroscopy confirmed the incorporation of Cu(I) with a K-edge at 8995 
eV and a distinct shoulder at 8983 eV corresponding to the characteristic 1s4p 
transition observed on excitation of Cu(I) (Figure 17B; Ferraroni et al., 1999).  
To confirm the role of Cys-53 in binding copper, the Cys-53 was mutated to an alanine 
using PCR mutagenesis and the untagged mutant construct was expressed and purified 
using the same protocol as with the wild-type protein (Figure 18A). DJ-1 C53A protein 
(DJ-1
C53A
) was incubated with molar excess of Cu(I) anaerobically and the electronic 
absorbance spectrum was recorded. Unlike the wild-type protein, DJ-1
C53A
 did not show 
a Cu(I)-Sγ specific absorbance at 254 nm, confirming the structural role of Cys-53 in 
copper binding (Figure 18B). 
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Figure 15. Crystal structure of the metal-bound DJ-1. (A) The hexagonal 
bipyramidal crystals of DJ-1 used for the metal soaking experiments are shown. Scale 
bar = 0.5 mm. (B) Cartoon representation of the crystal structure of DJ-1 with the Cu(I) 
(orange sphere) bound at the homodimer interface. One protomer is green and the other 
is cyan in the DJ-1 homodimer.  The atomic coordinates and structure factors have been 
deposited in the Protein Data Bank (PDB ID: 4BTE). Panel C shows the anomalous 
difference map (grey, contoured at 10.0σ) of the Cu(I) binding site with the cysteinyl  
Sγ distances to the metal centre in Å. Structures were rendered using PyMol (Delano, 
2002). 
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Figure 16. Structural alignment of apo- and Cu(I)-bound DJ-1. Superposition of the 
backbone traces of the apo-DJ-1 (black trace; PDB ID code:1PDV) and the Cu(I)-DJ-1 
complex (magenta trace; PDB ID code: 4BTE) indicated no gross conformation changes 
upon binding of Cu(I) to DJ-1. The backbone RMSD of the Cu(I) bound structure to the 
apoprotein form was within 0.2 Å. The copper ion is shown as an orange sphere. 
Structures were rendered using Pymol (Delano, 2002). 
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Table 2. Data collection and refinement statistics for Cu(I)-bound DJ-1. 
 Cu(I)-bound DJ-1 
 
Data collection  
Space group  P3121   
Cell dimensions  
a, b, c (Å) 75.26, 75.26, 75.35   
α, β, γ (°) 
 
90, 90, 120 
Resolution (Å)  26.2 (1.34 – 1.38)*  
Rmerge  0.077 (0.438)  
I / σI  34.8 (3.1)  
Completeness (%)  89.5 (15.2)  
Redundancy  28.9 (3.8)  
 
Refinement  
dmin (Å)  1.38  
No. reflections  43643 
Rwork/ Rfree  0.1184/ 0.1498 
No. atoms  
  Protein  1391  
  Cu(I)  1  
  Water  218  
 
B-factors (Å
2
) 
  Protein  15.9  
  Ligand/ion  66.6  
  Water  42.4 
 
RMSD  
Bond lengths (Å)  0.0249 
Bond angles (º)  2.183 
 * Values in parentheses are for the highest resolution bin. 
56 
 
 
Figure 17. Spectroscopic analysis of Cu(I)-bound DJ-1 in crystallo. (A) Difference 
electronic absorption spectrum of the crystal soaked in Cu(I)-GSH indicating the 
interaction of Cu(I) with thiolate moieties. Spectrum was obtained by normalisation of 
the protein content followed by the subtraction of the spectrum of the non-derivatised 
DJ-1 crystal from the spectrum of the soaked crystal. (B) Fluorescence spectra of DJ-1 
derivatised with either Cu(I) (red) or Cu(II) (blue). The shoulder (indicated by the arrow) 
before the Cu K-edge confirms the presence of Cu(I). 
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Figure 18. Cu(I) binding analysis of recombinant DJ-1
C53A
. (A) Protein was 
produced in E. coli BL21(DE3) cells, transformed with the appropriate pET-28a 
construct of DJ-1 with a C53A mutation. Purification was performed using phenyl 
sepharose and Q-sepharose chromatography. An aliquot of the final eluate was analysed 
by SDS-PAGE using a 12% w/v acrylamide gel stained with Coomassie R-250. Lane 1: 
Pierce PageRuler unstained molecular weight marker with indicated sizes in kDa, lane 2: 
Purified untagged DJ-1
C53A
. (B) Proteins were prepared in N2-purged buffer containing 
25 mM Tris pH 7.5, 100 mM NaCl. Two-fold molar excess of Cu(I) was added to apo-
proteins anaerobically and the electronic absorbance spectra were recorded. 
[Cu(CH3CN)4]PF6 was used as Cu(I) source. Spectra from Cu(I)-incubated proteins 
were normalised against the spectrum of the Cu(I) titrant. 
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2.2.5 DJ-1 binds Cu(I) with subfemtomolar affinity 
Copper chaperones possess a high affinity for their cognate metal ion because of the 
controlled supply of copper ions in the intracellular milieu (Rae et al., 1999; Xiao et al., 
2011). The majority of the copper chaperones have subfemtomolar affinity in order to 
retain the metal ion inside the cell (Xiao et al., 2011). 
To accurately measure the copper affinity of DJ-1, the Cu(I) exchange between DJ-1 
and  bicinchoninic acid (Bca), shown in the equation below, was carried out in both 
directions. 
CuI(DJ-1)
2
 + 2Bca               (DJ-1)
2
 + CuI(Bca)
2
3-
 
Bca is a Cu(I)-specific chelator that forms a chromophoric complex with an accurately 
measured formation constant (β) equal to 1017.2 M-2 (Zhou et al., 2008; Xiao et al., 
2011). To ensure that all Cu(I) ions are bound, the Cu
I
(DJ-1)2 and Cu
I
(Bca)2
3-
 
complexes were prepared by preincubating a molar excess of either DJ-1 dimer or Bca, 
respectively, relative to Cu(I). When equilibrium was reached, the concentration of each 
component was quantified which then enabled the calculation of the dissociation 
constant using the equation described in the section 5.5.4. An average dissociation 
constant of 6.41 x 10
-16
 M was estimated for the Cu
I
(DJ-1)2 complex (data shown in 
Table 3). This is in the same range as other human copper binding proteins such as 
Atox1 (10
-17.4
 M, Xiao and Wedd, 2010) and WLN5-6 (10
-17.6
 M, Xiao et al., 2011), 
highlighting the ability of a Cu
I
(DJ-1)2 complex to form under physiological conditions. 
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Table 3. Dissociation constant for Cu
I
(DJ-1)2 complex based on competition with 
bicinchoninic acid (Bca). 
[(DJ-1)2]total (µM)  25
a
 25
a 
25
a 
25
b 
25
b 
25
b 
[Bca]total (µM)  280 560 650 750 1000 1250 
[Cu(I)]total (µM)  10 10 10 10 10 10 
[Cu(Bca)2
3-
]eq (µM)  3.43 5.37 3.93 7.15 8.51 8.92 
[Cu
I
(DJ-1)2]eq (µM)  6.57 4.63 6.07 2.85 1.49 1.08 
Kd (x 10
-16
 M) 8.14 4.94 1.88 6.48 8.78 8.21 
Average Kd (x 10
-16
 M) = 6.41 ± 1.07
c 
Assay was performed in copper-free phosphate-buffered saline. 
a
Data from addition of 
Bca into Cu(I)-bound DJ-1. 
b
Data from addition of DJ-1 into Cu(Bca)2
3-
. 
c
Error shown 
as ± SEM. 
 
2.2.6 DJ-1 does not stimulate the activity of SOD1 in vitro 
To test the role of the copper binding site in the DJ-1 dependent activation of SOD1, 
recombinant wild-type DJ-1 and DJ-1
C53A
 were assayed for stimulation of SOD1 
activity in vitro using a method established by Rae et al. (2001). The recombinant form 
of SOD1 was expressed and purified to homogeneity (Figure 19). A demetallation step 
was carried out to remove the copper ion in the active site of as-isolated SOD1. The 
percentage of SOD1 activity after demetallation was less than 5%.  
Copper-dependent activation of apo-SOD1 was performed in anaerobic conditions. 
Since the activation of SOD1 requires oxygen, reaction mixtures were assayed 
aerobically. Cu(I)-GSH, which has been shown to be capable of activating apo-SOD1 in 
vitro (Ciriolo et al., 1990), was used as a positive control. Consistently, the Cu(I)-GSH 
complex was capable of stimulating SOD1 activity. However, neither wild-type DJ-1 
nor DJ-1
C53A
 showed substantial stimulation of SOD1 activity (Figure 20). The lack of 
in vitro activation suggests that an unknown cellular factor may be required to facilitate 
the interaction and/or activation of SOD1 by DJ-1. An alternative protocol was 
performed by our collaborators in Stavanger University Hospital (Norway) whereby DJ-
1 proteins were immunoprecipitated from MEF DJ-1
-/-
 back-transfected with wild-type 
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or the C53A variant to capture factors that may mediate the copper transfer. The 
immunoprecipitated proteins were then incubated with apo-SOD1. However, neither 
wild-type DJ-1 nor the C53A variant exhibited an ability to activate apo-SOD1 
(Appendix 1). Thus far, our results fail to show the DJ-1 dependent stimulation of 
SOD1activity reported by Xu et al. (2010).   
 
 
Figure 19. SDS-PAGE analysis of purified human SOD1. Protein was produced from 
E. coli BL21 (DE3) pLysS transformed with the pLEICS-03 SOD1 plasmid. A protein 
extract was prepared from the cells and was fractionated using Ni
2+
-affinity resin 
(Qiagen). An aliquot of the final eluate was analysed by SDS-PAGE using a 12% w/v 
acrylamide gel stained with Coomassie R-250. Lane 1: Pierce PageRuler unstained 
molecular weight marker with sizes indicated in kDa, lane 2: Purified recombinant 
SOD1.  
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Figure 20. SOD1 activity assays in vitro. Untagged wild-type DJ-1 and its C53A 
variant were loaded with 30 µM of Cu(I)-GSH complex and desalted to remove 
unbound metal ions. The DJ-1 proteins were then incubated with 15 µM apo-SOD1 and 
15 µM zinc acetate at 37°C for 1 hour and assayed using a Sigma SOD assay kit. Holo-
SOD1 was prepared by incubating apo-SOD1 with 30 µM Cu(I)-GSH complex. SOD1 
activity was measured as percent inhibition rate of WST-1 conversion to WST-1 
formazan by the substrate superoxide. Error bars represent standard deviation. Data (n = 
3) were collected in three independent experiments. **Unpaired t-test indicates that the 
difference is not statistically significant relative to the activity of apo-SOD1.   
 
2.2.7 DJ-1 does not interact with SOD1  
To determine if the recombinant forms of DJ-1 and SOD1 are capable of direct 
interaction, protein mixtures of DJ-1 and SOD1 variants were subjected to nESI-MS. 
We first determined whether the apo-DJ-1 and the copper-free, zinc-loaded SOD1 (Zn-
SOD1) could form a complex. The mass spectrum of an equimolar mixture of apo-DJ-1 
and Zn-SOD1 showed various charge states corresponding to dimers and tetramers of 
DJ-1 and SOD1 but no peaks for a binary complex were observed (Figure 21A). 
Interaction between DJ-1 and Zn-SOD1 perhaps requires a copper ion, thus, we 
recorded the mass spectrum of copper-loaded DJ-1 incubated with Zn-SOD1. However, 
**                       ** 
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none of the resulting m/z states indicated the formation of a DJ-1-SOD1-Cu ternary 
complex (Figure 21B). The rate of copper transfer could be extremely fast thus making 
it difficult to capture the complex. Interaction between SOD1 and CCS was successfully 
trapped through phenylalanine substitution of an SOD1 copper binding residue His-48 
and serine substitution of Cys-146 involved in the internalisation of the delivered 
copper ion to the active site (Lamb et al., 2001). To capture the potential protein 
complex between DJ-1 and SOD1, an analogous SOD1 H46F/C146S variant (HCV) 
expressed and purified from E. coli (Figure 22), was incubated with copper-loaded DJ-1 
and the mass spectrum of the mixture was recorded (Figure 22C). No peaks 
corresponding to a binary complex were formed suggesting that the interaction of the 
recombinant forms of DJ-1 and SOD1 does not exist under the conditions we have 
tested (Figure 21C). This provides a molecular explanation for the lack of SOD1 
activation by DJ-1. 
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Figure 21. nESI analysis of interaction between DJ-1 and SOD1. (A) Mass spectrum 
of apo-DJ-1 incubated with Zn-SOD1. (B) Mass spectrum of copper-loaded DJ-1 mixed 
with Zn-SOD1. (C) Mass spectrum of the mixture of copper-loaded DJ-1 and the SOD1 
H46F/C146S double mutant, HCV. 
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Figure 22. SDS-PAGE analysis of purified HCV. Protein was produced in E. coli 
BL21 (DE3) pLysS transformed with the pLEICS-03 SOD1 H46F/C146S (HCV) 
plasmid. A protein extract was prepared from the cells and was fractionated using Ni
2+
-
affinity resin (Qiagen). An aliquot of the final eluate was analysed by SDS-PAGE using 
a 12% w/v acrylamide gel stained with Coomassie R-250. Lane 1: Pierce PageRuler 
unstained molecular weight marker with sizes indicated in kDa, lane 2: Purified HCV.  
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2.3 Discussion 
The redox activity of copper ions is exploited by several proteins to carry out vital 
cellular processes. However, the same chemical reactivity can lead to deleterious effects 
in the cell, hence, the tight regulation of copper’s intracellular availability (Rae et al., 
1997). To facilitate the proper distribution and homeostatic control of copper, the cell 
employs copper binding proteins to handle the storage and delivery of the metal ion. DJ-
1 is a protein that has been suggested to be capable of delivering the copper cofactor of 
SOD1 and/or sequester free copper ions to prevent toxic accumulation in the 
intracellular milieu (Xu et al., 2010; Bjorkblom et al., 2013). In this chapter, we defined 
the molecular determinants that allow DJ-1 to function as a copper carrier.  
Cuprous and cupric ions are the two oxidation states of copper that are relevant to 
biological processes (Davis and O’Halloran, 2008). Previous work by Xu et al. (2010) 
has shown that DJ-1 binds Cu(II), however, because of the reducing nature of the 
cytosol, Cu(I) is more likely the physiological form  bound by DJ-1. Indeed, Cu(II) 
incubation of DJ-1 results in the formation of aggregates interlinked via disulphide 
bridges (Figure 23). Using electronic absorption spectroscopy, we have demonstrated 
the interaction of DJ-1 with Cu(I) and obtained information about the nature of ligation 
i.e. metal interaction through thiolate moieties. Mass spectrometric techniques 
consistently showed that one Cu(I) is held by each DJ-1 homodimer. Furthermore, 
nESI-MS results suggested that glutathione may also coordinate the copper ion, as has 
been observed in other copper binding proteins (Ralle et al., 2003; Ralle et al., 2004). 
However, glutathione was not observed in the crystal structure of Cu(I)-bound DJ-1. 
Crystal packing might have occluded the incorporation of the glutathione species. 
Our crystallographic analysis of copper-bound DJ-1 reveals the first high resolution 
structure of a copper trafficking protein that forms a Cu(I)-biscysteinate complex 
whereby the thiolate  
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Figure 23. Cu(II)-induced aggregation of DJ-1. (A) Untagged DJ-1 (5 µM) was 
incubated with various concentration of CuSO4 for 5 minutes. The reaction mixtures 
were quenched with SDS-PAGE sample buffer and heated for 5 minutes. Protein 
samples were analysed using SDS-PAGE. (B) DTT treatment of DJ-1 aggregates 
induced by CuSO4 reverses protein aggregation. 
ligands are coming from two separate subunits of the protein rather than from the 
canonical sequence motifs CXXC or CXC (Pufahl et al., 1997; Davis and O’Halloran, 
2008). Biscysteinate metal binding sites fulfill the requirements of a good metal ion 
donor. Firstly, they possess high metal affinity to acquire copper ions from a strictly 
limited intracellular pool. We have measured a subfemtomolar dissociation constant (Kd 
= 6.4 x 10
-16
 M) for the Cu
I
(DJ-1)2 complex, consistent with other human copper 
chaperones with similar biscysteinate sites such as Atox1 (3.9 x 10
-18
 M)  and the N-
terminal metal-binding domains 5 and 6 of the Wilson disease protein WLN5-6 (2.5 x 
10
-18
 M) (Xiao et al., 2011). Such high affinity supports the physiological retention of 
Cu(I) by DJ-1 inside the cell. Secondly, the low coordination number of biscyteinate 
sites is also favourable for ligand-exchange and metal transfer mechanisms. 
Biscysteinate sites form high-order complexes with residues (usually cysteines) of the 
cognate protein to facilitate metal transfer (Davis and O’Halloran, 2008).  
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SOD1 acquires its copper cofactor mainly through CCS (Culotta et al., 1997; Wong et 
al., 2000). But a CCS-independent pathway of copper acquisition has also been reported 
(Leitch et al., 2009). Factors directly mediating this alternative pathway remain largely 
unknown. The report by Xu et al. (2010) of a copper-dependent stimulation of SOD1 
activity by DJ-1 prompted us to determine whether DJ-1 contributes to the CCS-
independent pathway. Thus, to show direct copper chaperone activity of DJ-1, the 
protocol developed by Rae et al. (2001) was used whereby copper loading to DJ-1 and 
copper transfer to SOD1 was performed in an anaerobic environment followed by 
measurement of SOD1 activity under aerobic conditions. In contrast to the previous 
report of Xu et al. (2010), no significant stimulation of SOD1 activity by DJ-1 was 
demonstrated under the conditions tested. Similarly, our collaborators failed to show 
activation of SOD1 by DJ-1 purified from mammalian cells. The absence of DJ-1-
dependent SOD1 activation led us to determine whether the two proteins interact using 
nESI-MS. However, neither the absence nor the presence of copper in the mixture of 
recombinant DJ-1 and SOD1 showed the formation of a binary complex between the 
two proteins. Hence, our results are not consistent with the ability of DJ-1 to activate 
SOD1 in vitro. Initial data from our cell-based assays suggest that DJ-1 copper binding 
site does not considerably influence the intracellular SOD1 activity and the steady-state 
levels of superoxide radicals (Figure 24). Thus, the role of the copper binding site is not 
likely involved in the activation of SOD1. 
Using X-ray fluorescence, Bjorkblom et al. (2013) reported the ability of DJ-1 to 
selectively sequester copper and mercury albeit no information on the residues involved 
in metal binding. Additionally, they have shown that DJ-1 was able to protect cells 
against the cytotoxicity induced by these metal ions (Bjorkblom et al., 2013). 
Environmental exposure to copper and mercury has been associated with an increased 
risk of developing PD (Gorell et al., 1997; Willis et al., 2010). Heavy metals e.g. copper 
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and mercury are potent neurotoxins, capable of inducing oxidative stress and damaging 
cellular macromolecules (Paik et al., 1999; Olivieri et al., 2000; Arciello et al., 2005; 
Yang et al., 2010). The ability of DJ-1 to sequester copper and mercury is therefore 
important in the context of metal-induced neurodegeneration. Consistently, 
parkinsonism-linked mutations e.g. A104T and D149A abolished the cytoprotection 
conferred by DJ-1 against metal-induced cell death (Bjorkblom et al., 2013).  
 
Figure 24. Cys-53 role in superoxide level modulation and SOD1 activation in vivo. 
(A) shows the relative intracellular SOD1 activity in SH-SY5Y cells stably transfected 
with wild-type DJ-1 or the C53A variant. Cells were treated with 20 µM menadione to 
induce production of superoxide. Error bars represent standard deviation. Data (n = 3) 
were collected in three independent experiments.*Unpaired t-test indicates that the 
difference is statistically significant with a two-tailed p < 0.001. (B) Intracellular 
superoxide levels were measured using FACS analysis of DHE-stained SH-SY5Y cells 
stably transfected with a pCDNA 4 myc/His A vector expressing wild-type DJ-1, a 
C53A variant, or the empty vector. Superoxide production was induced by treating the 
cells with 20 µM menadione for 30 minutes prior to staining. The bar graph shows the 
average relative DHE fluorescence from three independent experiments (n = 3). Each 
experiment counts 10 000 cells. Relative fluorescence of the empty vector was set to 
100%. Error bars represent ± SEM.** Unpaired t-test indicates that the difference is not 
statistically significant. (C) Western blot analysis of ectopically expressed DJ-1 in SH-
SY5Y stable-transfected cell lines. 
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Our work elucidates the critical role of Cys-53 in metal sequestration, providing a 
structural basis by which DJ-1 overexpression could prevent the damaging reactions of 
free copper ions in the intracellular milieu. Mercury, a structural analogue of copper, 
has been found to bind biscysteinate sites of copper binding proteins (Larin et al., 1999; 
Wernimont et al., 2000). Thus, mercury would likely be held by Cys-53, allowing DJ-1 
to modulate its cytotoxic effects. Sequence alignment of DJ-1 homologues across 
different species shows that Cys-53 is only conserved among vertebrates (Figure 25). 
This suggests that the ability of DJ-1 to bind copper is an emergent function that 
perhaps has been developed by vertebrates to tightly regulate copper homeostasis. 
Because the copper binding site requires a DJ-1 homodimer, PD-linked mutations e.g. 
L10P, L158del, L166P, M26I, and E163K that disrupt homodimerisation would impair 
the ability of DJ-1 to sequester copper. The loss of cytoprotection against metal toxicity 
observed for the PD-linked A104T and D149A, are likely due to the fact that these 
mutations decrease DJ-1 homodimerisation (Moore et al., 2005), potentially reducing 
the ability of these variants to form a copper binding site. Bjorkbolm et al. (2013) have 
also demonstrated that dopamine augmented the toxicity of the metals and significantly 
reduced the cytoprotection conferred by DJ-1. Cytosolic accumulation of dopamine has 
been shown to induce the covalent modification of Cys-53 by dopamine-derived 
quinones (Girotto et al., 2012). This modification would render DJ-1 incapable of metal 
binding, thus explaining the reduced cytoprotective effect of DJ-1 when cells were co-
treated with dopamine and metals (Bjorkbolm et al., 2013). Cys-53 can also be 
modified through S-nitrosylation (Ito et al., 2006) and oxidation (Choi et al., 2006). 
These chemical alterations of Cys-53 would impair the ability of DJ-1 to sequester 
copper/mercury and as a result could increase the vulnerability of dopaminergic neurons 
to abnormal levels of copper/mercury. 
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Figure 25. Protein sequence alignment of DJ-1 homologues. The copper binding 
cysteine Cys-53, highlighted in red, is only conserved among vertebrates. Residues with 
high degree of conservation are highlighted in blue. The alignment was generated using 
CLUSTALW and visualised using Jalview 2.8. 
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Chapter 3 
Structural and functional characterisation of the  
Parkinsonism-linked DJ-1 A107P mutant 
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3.1 Introduction 
 
A missense mutation in DJ-1 involving a proline substitution of Ala-107 was isolated in 
a patient diagnosed with early-onset familial PD (Ghazavi et al., 2011). The mechanism 
by which this mutation disrupts DJ-1 function is unknown. Ala-107 is adjacent to the 
highly conserved Cys-106 residue that is essential for DJ-1 to carry out many of its 
cellular activities including glyoxalase (Lee et al., 2012), weak protease (Chen et al., 
2010), molecular chaperone (Zhou et al., 2006), and mRNA translational control (van 
der Brug et al., 2008).  
Ala-107 and Cys-106 are both found in a motif called the nucleophile elbow (Figure 24). 
This motif is a distinct structural element first described in the active sites of α/β 
hydrolases (Ollis et al., 1992; Nardini and Dijkstra, 1999). It is identified by the 
consensus sequence Sm-X-Nu-X-Sm where Sm = a small residue e.g. Ala or Gly, Nu = 
nucleophile, and X = any residue. The sequence A-I-C-A-G/A is found in the 
nucleophile elbow motifs of prokaryotic and eukaryotic homologues of DJ-1. The motif 
positions the nucleophilic residue (Cys) in a tight turn of a strand-helix transition 
(Figure 26; Ollis et al., 1992; Nardini and Dijkstra, 1999). The sharpness of the turn 
results from the energetically unfavourable backbone torsion angles (φ = 66°, ψ = -117° 
in human DJ-1) of the nucleophilic residue (Ollis et al., 1992). Thus far, mutational 
analyses of the nucleophile elbow motif have focused on its role in catalysis. The role of 
nonenzymatic residues in the structural integrity of the active site and the protein fold as 
a whole has not been characterised.  
This chapter presents the structural and functional consequences of the disease-linked 
A107P mutation in DJ-1. We produced recombinant forms of the A107P variant and 
tested its ability to act as a glyoxalase. Subcellular localisation, oligomeric state, and 
intracellular steady-state level of the A107P mutant were compared with the wild-type 
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protein to identify the aspects of DJ-1 function that may be perturbed by the mutation. 
Structural analysis using CD and NMR spectroscopy of the A107P variant was also 
carried out to determine the effects of the mutation on the structure of the active site and 
the DJ-1 fold. In essence we found that the A107P mutation not only impaired the 
ability of DJ-1 to act as a glyoxalase but remarkably disrupted the proper folding of the 
protein. 
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Figure 26. The nucleophile elbow motif of human DJ-1.  Cartoon representation 
depicts the nucleophile elbow found in β7-loop-α5 of DJ-1 (PDB ID code: 1PDV) 
whereby the backbone torsion angles of the nucleophilic residue Cys-106 adopt an 
unfavourable conformation (upper panel). Structure was rendered using Pymol (Delano, 
2002). The nucleophile elbow motif is conserved in various prokaryotic and eukaryotic 
homologues of DJ-1. Cys-106 and Ala-107 residues (numbered as in human DJ-1) are 
marked with (*) and (#), respectively. 
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3.2 Results 
3.2.1 Bacterial expression of DJ-1 A107P variant
 
Recombinant forms of DJ-1 have been useful in vitro models to compare the intrinsic 
structural properties and biochemical activities of the wild-type protein relative to the 
ones with disease-linked mutations (Lakshminarasimhan et al., 2008; Malgieri and 
Eliezer, 2008). Hence, we expressed recombinant wild-type DJ-1, DJ-1 with the PD-
linked A107P mutation (DJ-1
A107P
) and DJ-1 with glyoxalase-inactivating alanine 
substitution of Cys-106 (DJ-1
C106A
) in Escherichia coli and purified the proteins to 
homogeneity. The protein expression level of DJ-1
A107P
 is greatly diminished compared 
to the wild-type protein suggesting a negative effect of the mutation on the solubility or 
stability of the protein inside the cell (Figure 27). The estimated molecular size of DJ-1
 
A107P
 is 53 kDa (theoretical molecular size for monomer = 21 kDa) as determined by 
size exclusion chromatography (Figure 28). The molecular size of DJ-1
A107P
 is closest to 
a homodimeric species albeit a larger size than wild-type DJ-1 dimers. Results from our 
collaborators in Tuebingen, however, indicated the lack of homodimerisation exhibited 
by DJ-1
A107P
 ectopically expressed in human embryonic kidney (HEK) 293E cells 
(Appendix 2). Therefore, the apparently larger molecular size of DJ-1
A107P
 suggests an 
increase in the hydrodynamic volume of the monomeric protein that may be due to 
some degree of disordered structure caused by the mutation, as observed with some 
intrinsically disordered proteins such as α-synuclein which has a molecular size of 14 
kDa but runs as a 65 kDa monomeric protein in SEC (Burre et al., 2013). 
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Figure 27. Purified recombinant DJ-1 proteins produced in bacteria. Proteins were 
expressed in E. coli BL21(DE3) cells, transformed with the appropriate pET-28a DJ-1 
construct. Recombinant proteins were obtained using Ni-NTA affinity chromatography 
and analysed using a 12% w/v acrylamide SDS-PAGE. Proteins were purified from 
equal amounts of bacterial cell lysates to ascertain the effect of mutations on the protein 
expression levels. The leftmost lane shows the molecular weight marker in kDa 
(Pharmacia). 
 
Figure 28. Comparative size exclusion chromatography analysis of wild-type DJ-1 
and DJ-1
A107P
. Proteins (1 mg/ml) were separated using Sephacryl S-100 with 20 mM 
Tris pH 7.15, 100 mM NaCl as mobile phase. Chromatograms of wild-type DJ-1 (blue 
curve) and DJ-1
A107P
 (red curve) were overlaid for comparison (left panel). A calibration 
curve was used to estimate the apparent molecular size of the proteins using bovine 
serum albumin (BSA), β-lactoglobulin, and cytochrome c (cyt c) as standards (right 
panel).  
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3.2.2 A107P mutation abolishes DJ-1 glyoxalase activity
 
The mutation A107P is located adjacent to the highly conserved Cys-106 that acts as the 
nucleophilic residue in the glyoxalase active site of DJ-1. To determine if the mutation 
affects the glyoxalase activity of DJ-1, we estimated the catalytic rate constant (kcat, 
min
-1
) using glyoxal as the substrate (Figure 29A). The unreacted substrate 
concentration was measured using a quantitative DNPH assay for aldehydes (Lee et al., 
2012). In accord with a previous report, the kcat for wild-type DJ-1 was estimated to be 
198 min
-1
 (Lee et al., 2012). In contrast, DJ-1
A107P
 exhibited a negligible kcat similar to 
the active site mutant DJ-1
C106A
 control. This infers that the mutation makes DJ-1 
incapable of catalysing the detoxification of glyoxal perhaps resulting from disruption 
of the structural integrity of the active site. 
We then correlated the in vitro glyoxalase activity assay results with the ability of the 
mutant protein to protect cells against glyoxal-induced cytotoxicity. Wild-type and 
mutant proteins were prepared with an N-terminal His6 tag to allow purification and a 
tat transduction domain (RKKRRQRRR) that has been used previously to facilitate cell 
internalisation (Figure 30A; Batelli et al., 2008). Tat-fused proteins were successfully 
transduced into a  mouse embryonic fibroblast (MEF) DJ-1
-/-
 cell line and human 
neuroblastoma SH-SY5Y cell line (Figure 30B). We have used 2 mM glyoxal to induce 
cytotoxicity according to Lee et al. (2012) protocol. In both cell lines, transduction of 
wild-type DJ-1 protein conferred protection against reduction in cell viability induced 
by glyoxal (Figure 29B). In contrast, neither the A107P variant nor the C106A variant 
protected either cell lines from glyoxal cytotoxicity (Figure 29B). This is consistent 
with the abrogation of glyoxalase activity caused by the A107P mutation. Notably, SH-
SY5Y cells were more vulnerable to glyoxal than MEF DJ-1
-/-
 cells. We posit that the 
embryonic knockout of DJ-1 may induce a compensatory mechanism whereby other 
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glyoxalase scavenging mechanisms are upregulated in the absence of DJ-1, although 
this requires further investigation.  
Glyoxal cytotoxicity is accompanied by the formation of advanced glycation end 
products such as Nε-carboxymethyllysine (CML) (Glomb and Monnier, 1995). CML 
modification of proteins can lead to protein aggregation and inactivation, contributing to 
glyoxal’s deleterious effect on cell viability (Munch et al., 2012). An antibody against 
CML allowed the detection of total cellular proteins modified with CML. Protein 
extracts from glyoxal-treated SH-SY5Y cells transduced with the active site mutant 
C106A showed remarkable immunoreactivity against the CML antibody, consistent 
with the accumulation of CML-modified proteins as a result of glyoxal treatment 
(Figure 29C). Conversely, transduction of wild-type protein into SH-SY5Y cells 
prevented the build up of CML-modified proteins after glyoxal treatment, 
demonstrating the ability of DJ-1 to detoxify glyoxal. Immunoblot analysis of cells with 
the DJ-1
A107P
 showed a concomitant accumulation of CML upon glyoxal treatment, 
confirming the lack of glyoxalase activity caused by the A107P mutation. 
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Figure 29. The A107P mutation abrogates the ability of DJ-1 to protect against 
gloxal cytotoxicity and accumulation of CML. (A) Catalytic efficiencies of wild-type 
(wt) and mutant proteins were obtained using a DNPH-based quantitative assay. Error 
bars are ± 2 SD obtained from data (n = 3) in three independent repeats. (*) denotes p < 
0.0001 in an unpaired t-test. (B) Bar graphs showing the percent cell viability after 
glyoxal treatment of MEF DJ-1
-/-
 (upper panel) and SH-SY5Y cells (lower panel) 
transduced with various DJ-1 variants. Cell viability was measured using the Prestoblue 
assay (Life Technologies). Data (n = 25 for MEF; n=16 for SH-SY5Y) were collected in 
three independent experiments. Error bars represent SD. (*) denotes p < 0.0001 in an 
unpaired t-test. (C) Western blot analysis of CML-modified proteins in glyoxal-treated 
SH-SY5Y cells transduced with either wild-type or mutant DJ-1 proteins. Levels of β-
actin were probed to show equal loading for each sample. 
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Figure 30. Immunoblot analysis of transduced DJ-1 proteins in MEF and SH-
SY5Y cells. (A) Diagram of the tat-fused DJ-1 construct used in cells assays. (B) SDS-
PAGE analysis of tat-fused DJ-1 proteins expressed in E. coli BL21 (DE3) and purified 
using Ni
2+
-affinity (Qiagen) and anion-exchange (Q-sepharose, GE Healthcare) 
chromatography. The leftmost lane shows the molecular weight marker with the 
indicated sizes in kDa (Pharmacia). (C) Recombinant tat-fused proteins were 
successfully transduced into MEF DJ-1
-/-
 and SH-SY5Y cells. Cells were grown for 24 
hours prior to transduction. To allow internalisation, cells were incubated with 10 µM 
tat-fused proteins in serum free media for at least 2 hours prior to assay. β-actin was 
used as a loading control. 
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3.2.3 Clues on the catalytic role of Ala-107 from in silico analysis and the crystal 
structure of DJ-1 bound to SO4
2-
 and glycerol   
To elucidate the effect of the A107P mutation on the molecular architecture of the 
glyoxalase active site of DJ-1, we have attempted to crystallise the DJ-1 with the A107P 
mutation. Previously determined conditions used to crystallise DJ-1 mutants did not 
yield crystals, thus we set up crystallisation screens to find new conditions that would 
crystallise the mutant. JCSG-plus HT Condition D3 (0.2 M sodium chloride, 0.1 M 
sodium dihydrogen phosphate, 0.1 M potassium dihydrogen phosphate, 50.0% v/v 
polyethylene glycol 200) gave a crystal but when diffracted, the crystal turned out to be 
salt. 
Failing to get a crystal, the structural effects of the A107P mutation were analysed by in 
silico mutagenesis of the protein. Mutagenesis was carried out in Coot (Emsley and 
Cowtan, 2004). In the structure of the wild-type protein, the backbone torsion angles (φ 
= 66°, ψ = -117°) of the nucleophilic residue Cys-106 lie in the unfavourable region of 
the Ramachandran plot, a diagram of allowed backbone conformations in proteins as 
indicated by φ, ψ dihedral angles. Such an unusual backbone strain on the nucleophilic 
residue is a distinct feature of the nucleophile elbow motif that likely contributes to the 
chemical reactivity and proper orientation of the nucleophile (Ollis et al., 1992; Nardini 
and Dijkstra, 1999). The role of non-nucleophilic residues in the motif in dictating the 
unique conformation of the nucleophile has not been explored. Measurement of the 
torsion angles of Cys-106 in the in silico model suggests that proline substitution of the 
Ala-107 (of the human DJ-1 nucleophile elbow motif A104-I105-C106-A107-G108) does not 
drastically change the backbone torsion angles (φ = 66°, ψ = -114°) of Cys-106, with ψ 
only changing by 3 degrees (Figure 31A). The Ramanchandran plot of the A107P 
mutant generated using Chimera (Pettersen et al., 2004) indicated that the Cys-106 
backbone conformation remained in the disallowed region, suggesting that the mutation 
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does not alter Cys-106 nucleophilicity via changes in Cys-106 backbone conformation 
(Figure 31B). 
Site directed mutagenesis of the putative active site residues suggested a reaction 
mechanism for DJ-1 glyoxalase activity whereby Glu-18 not only contributes to the 
chemical reactivity of Cys-106 nucleophile but also acts as a general base (Lee et al., 
2012). However, the function of the nonenzymatic residues e.g. Ala-107 in the 
nucleophile elbow motif have not been characterised. To determine the potential role of 
Ala-107 in the catalytic mechanism of DJ-1 glyoxalase activity, the crystal structure of 
DJ-1 with a substrate (methylglyoxal) bound to the active site and/or engaged in 
catalysis was sought. Wild-type protein or a variant whereby the nucleophilic residue 
Cys-106 was substituted for a serine to prevent the catalytic turnover of the substrate 
were used to produce crystals. To introduce the substrate we either grew the crystals 
using protein pre-incubated with molar excess of methylglyoxal or soaked the crystals 
in mother liquor supplemented with 1.2 M methylglyoxal for various incubation times. 
However, none of the crystals contained methylglyoxal in the active site when their 
structure was solved.  
Nonetheless, a crystal structure was determined with the C106S variant of the protein 
bound to a sulphate anion (carried over from purification procedure) and glycerol (a 
component of the crystallant) in the active site (Figure 32A-E; see Table 4 for data 
collection and refinement statistics). In this structure, the hydroxyl moiety of Ser-106 is 
displaced by 1.5 Å relative to the position of Cys-106 in the wild-type structure, perhaps 
to accommodate the sulphate anion. Glycerol, which we propose to mimic the substrate, 
is mainly bound by Arg-28’ (of subunit B) at the homodimer interface (Figure 32D). 
Arg-28’ is anchored to subunit A via guanidinium stacking with the side chain of Arg-
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48 (of subunit A). This suggests that the recruitment of the substrate to the active site 
potentially requires the formation of a homodimer. 
The sulphate anion is held through hydrogen bonding with the main-chain NH of Gly-
75 and Ala-107 and the side chains of Glu-18 and Ser-106 (Figure 32E). We propose 
that the sulphate anion mimics the tetrahedral transition state intermediate during the 
nucleophilic attack on the methylglyoxal aldehyde carbon by the thiolate group of Cys-
106 (Kwon et al., 2013). The oxyanion formed during the transition state is potentially 
stabilised by an oxyanion hole formed by the amide NH’s of Gly-75 and Ala-107. This 
is supported by a recent study by Buller and Townsend (2013). The authors analysed 
enzymes that use an acylation-based mechanism to look for geometric relationships 
within the active sites to predict the catalytic mechanism and stereochemistry of the 
reaction. They have found that the configuration of the reactive rotamer of the 
nucleophilic residue dictates which backbone NH moeity will stabilise the oxyanion in 
the transition state.  In the active site of DJ-1 where the nucleophilic Cys-106 thiol (–SH) 
group adopts a trans rotamer relative to the residue’s backbone NH group (Fig. 31C), 
the amide NH of the succeeding residue (Nu+1) is predicted to play a direct role in 
stabilising the oxyanion formed during nucleophilic attack (Buller and Townsend, 2013). 
Because the backbone nitrogen of a proline residue cannot donate a hydrogen bond, 
proline substitution of the residue Ala-107 (Nu+1) will not allow the formation of a 
stabilising oxyanion hole in the transition state. 
In summary, proline substitution of Ala-107 does not change the backbone torsion 
angles of Cys-106 but potentially affects the ability of DJ-1 to catalyse glyoxal 
detoxification by impairing the formation of an oxyanion hole during the nucleophilic 
attack. 
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Figure 31. In silico structural analysis of the A107P mutation. (A) A107P mutation 
was generated in silico using Coot wih DJ-1 PDB ID code: 1PDV as template. The in 
silico model suggests that the backbone torsion angles of Cys-106 in the A107P variant 
do not significantly deviate from the native conformation. (B) Ramachandran plot 
(general case and pre-proline) generated using Chimera (Pettersen et al., 2004) of wild-
type DJ-1 (PDB ID code: 1PDV) and the A107P mutant. (C) The thiol moiety of the 
cysteine residue adopts a trans configuration relative to the residue’s backbone amide. 
Structures were rendered using PyMol (Delano, 2002). 
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Figure 32. The glyoxalase active site of DJ-1 with sulphate anion and glycerol 
bound. (A) SDS-PAGE analysis of recombinant DJ-1 C106S mutant (right lane) 
expressed in E. coli BL21 (DE3). The left lane shows the molecular weight marker with 
the indicated sizes in kDa (Pharmacia). (B) Crystals of DJ-1 C106S mutant in a 
crystallant solution containing 20% v/v glycerol and 24% w/v PEG 1500. Scale bar = 
0.5 mm. (C) Fo-Fc electron density map (contoured at 2σ) of the sulphate anion and 
glycerol bound to the active site of DJ-1. (D) Noncovalent interaction of glycerol in the 
active site. Glycerol is held by Arg-28 of subunit B (in magenta). (E) Noncovalent 
interactions of the sulphate anion. Backbone amide NH moieties of Gly-75 and Ala-107 
donate hydrogen bonds to the sulphate oxyanion. Water molecules are shown as red 
asterisks. Dashed lines indicate hydrogen bonds. Structures were rendered using PyMol 
(Delano, 2002). 
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Table 4. Data collection and refinement statistics for DJ-1 C106S with glycerol and 
sulphate bound. 
 C106S – Glycerol/SO4
2-
 
 
Data collection  
Space group  P21212  
Cell dimensions  
a, b, c (Å) 43.86, 86.60, 49.52 
α, β, γ (°) 
 
90, 90, 90 
Resolution (Å)  12.12 (1.85 - 1.81)*  
Rmerge  0.036 (0.052) 
Mean I / σI  23.3 (12.8)  
Completeness (%)  98.7 (96.4)  
Redundancy  3.4 (2.2)  
 
Refinement  
dmin (Å)  1.81  
No. reflections  17549 
Rwork/ Rfree  0.150/ 0.1894 
No. atoms  
  Protein  1386 
  Glycerol 
  Sulphate  
6 
5  
  Water 
    
268 
 
B-factors (Å
2
)  
  Protein  8.9 
  Glycerol  11.6 
  Sulphate 8.4 
  Water  
 
22.2 
RMSD  
Bond lengths (Å)  0.008 
Bond angles (º)  1.17 
 * Values in parentheses are for the highest resolution bin. 
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3.2.4 Intracellular steady-state levels of DJ-1
A107P 
A number of PD-linked mutations in DJ-1 reduce the intracellular steady state levels of 
the protein (Olzmann et al., 2004; Ramsey and Giasson, 2010; Rannikko et al., 2012). 
To determine the effects of the A107P mutation on the protein levels of DJ-1, SH-SY5Y 
cells were transiently transfected with plasmid constructs of DJ-1 with a C-terminal 
His6 tag. Western blot analysis using antibodies against DJ-1 was used to compare the 
amount of the two proteins. As shown in Figure 33, the steady-state levels of the wild-
type DJ-1 are comparable to that of DJ-1
A107P
. This suggests that the A107P mutation 
does not lead to a rapid clearance of the protein in SH-SY5Y cells. RT-PCR was used to 
confirm equal mRNA expression levels of wild-type DJ-1 and DJ-1
A107P
 (Figure 33).  
Our collaborators in Tuebingen performed similar experiments and found that the 
steady-state level of DJ-1 varies between cell types and is not influenced by the 
presence of endogenous DJ-1 (Appendix 3). In HEK 293E, the DJ-1
A107P
 steady-state 
level was only slightly reduced compared to wild-type DJ-1. In contrast, when DJ-1
A107P
 
was ectopically expressed in MEF cells derived from either DJ-1
-/-
 mice or DJ-1
+/+
, the 
protein level of DJ-1
A107P
 was significantly diminished compared to the wild-type 
protein (Appendix 3). 
We have determined whether the A107P mutation alters the subcellular localisation of 
DJ-1. MEF DJ-1
-/-
 were back-transfected with DJ-1 plasmid constructs and the 
ectopically expressed proteins were detected using immunofluorescence. Wild-type DJ-
1 and DJ-1
A107P
 were detected in the cytosol (Figure 34). However, unlike the wild-type 
protein, DJ-1
A107P
 was absent in the nucleus. Notably, DJ-1
A107P
 was found in foci 
compared to the uniform cellular distribution of the wild-type DJ-1. 
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Figure 33. Steady-state levels of the DJ-1
A107P
 when expressed in SH-SY5Y cells. 
Left panel: SH-SY5Y cells were transiently transfected with DJ-1 pCDNA 4 constructs 
with the His6 tag. Twenty four hours post-transfection, cells were lysed and DJ-1 
detected using an anti-DJ-1 primary antibody (Enzo Life Sciences) and anti-mouse IgG 
secondary antibody conjugated with horseradish peroxidase (Sigma). β-actin was 
immunodetected as a loading control. Right panel: Equal mRNA expression of the 
constructs was determined using semi-quantitutive RT-PCR using primers specific for 
human DJ-1, with β-actin probed as a loading control. 
 
 
Figure 34. Subcellular localisation of DJ-1
A107P
. MEF DJ-1
-/-
 cells were transfected 
with pCDNA 4 DJ-1 constructs with a C-terminal His6 tag. After 24 hours, cells were 
immunodetected for DJ-1 using an anti-DJ-1 primary antibody (Enzo Life Sciences) and 
anti-mouse IgG secondary antibody conjugated with Alexa Fluor 488 (Life 
Technologies). The nuclei were counterstained with To-Pro-3 (Life Technologies). 
Magnified images of the boxed areas in the merged micrographs are shown at the 
rightmost panel. Micrographs were taken using the 60X objective of the Leica TCS SP2 
confocal microscope. Scale bar = 11 µm. 
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3.2.5 The A107P mutation leads to DJ-1 misfolding 
The reduced steady-state levels and loss of homodimerisation of DJ-1
A107P
 observed by 
our Tuebingen collaborators prompted us to further investigate the structural changes 
caused by the mutation.  
Changes in the secondary structure of the mutant protein were determined using circular 
dichroism (CD) spectroscopy. The far-UV region (200-260 nm) of the CD spectra of 
DJ-1
wt
 and DJ-1
A107P
 were recorded at room temperature (20°C). At physiological pH, 
the CD spectrum of the wild-type DJ-1 protein indicated a properly folded protein with 
maximum negative ellipticity between 208 nm to 220 nm that corresponds to well-
structured α-helices (Figure 35). The secondary structure content obtained using the 
K2D3 program (Louis-Jeune, 2012) estimated 38% α-helix, 20% β-sheet, and 42% 
coil/turn/other from the CD spectrum of the wild-type DJ-1 protein. This is consistent 
with the calculated secondary structure content derived from the crystal structure of DJ-
1 (38% α-helix, 20% β-sheet, 42% coil/turn/other) (Tao and Tong, 2003). In contrast, 
remarkable misfolding was evident in the far-UV CD spectrum of the A107P variant. 
The decrease in negative ellipticity was concomitant with the reduction in total alpha 
helical content (24.4% α-helix). However, the estimated β-sheet content (19.7% β-sheet) 
did not change. This suggests that DJ-1
A107P
 exhibits marked misfolding yet maintains 
some level of folded structures mainly comprising of β-sheets perhaps from the 
retention of a structured core. 
To further characterise the changes in the structure of the A107P variant, the 
1
H-
15
N 
HSQC spectra of the wild-type and mutant proteins were recorded (Figure 36). The 
spectrum of the wild-type DJ-1 protein displayed well-resolved resonance peaks typical 
for a well-folded protein. In contrast, the DJ-1
A107P
 spectrum showed poorly dispersed 
resonance peaks indicative of an ensemble of highly flexible protein conformational 
states caused by protein unfolding. These results do not support the presence of a well-
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ordered core as indicated by the CD spectrum. Interestingly, similar spectroscopic 
features were described for the L166P mutation (Malgieri and Eliezer, 2008). However, 
unlike the L166P variant (Olzmann et al., 2004), DJ-1
A107P
 is capable of 
heterodimerisation with the wild-type DJ-1 protein suggesting that a transient state 
exists that could potentially oligomerise with the wild-type DJ-1. The DJ-1
A107P
 
spectrum also revealed the perturbation of the structural framework of the glyoxalase 
active site of DJ-1 as indicated by the loss of the resonance peak corresponding to the 
active site residue Cys-106 (Figure 37), illuminating the deleterious effect of the A107P 
mutation on the enzymatic activity of DJ-1. 
Together, these results provide a molecular basis for the apparent decreased intracellular 
steady-state level of the DJ-1
A107P
 variant observed in HEK 293E and MEF cells. 
Furthermore, our results reveal a critical role for the nucleophile elbow motif residues 
not only in providing a structural integrity for the glyoxalase active site but also for the 
overall DJ-1 fold.  
 
  
Figure 35. CD spectra of wild-type DJ-1 and DJ-1
A107P
. CD spectra of proteins (7.5 
µM) in 20 mM HEPES pH 7.5, 50 mM NaCl were recorded at 20°C. 
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Figure 36. 
1
H-
15
N HSQC of wild-type DJ-1 and DJ-1
A107P
. The proton-nitrogen 
correlation NMR spectra of uniformly 
15
N-labelled proteins, wild-type DJ-1 (top panel) 
and DJ-1
A107P
 (lower panel), in 20 mM sodium phosphate pH 6.5 were recorded at 25°C. 
The well-dispersed correlation peaks in the HSQC spectrum of DJ-1
wt
 indicates the 
well-folded structure of the protein. Conversely, the poor dispersion of peaks in the DJ-
1
A107P
 is evidence for the misfolding caused by the mutation. The NMR data was 
collected by Altin Sula (Birkbeck/UCL) under the supervision of Dr. Mark Williams 
(Birkbeck/UCL). 
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3.3 Discussion 
A mutation screening of DJ-1 in PD patients with an average age of onset <31 years 
identified two novel mutations (Ghazavi et al., 2011). One of these is a point mutation 
that results in a proline substitution of Ala-107, a highly conserved residue located in 
the protein’s nucleophile elbow motif. In this chapter, the effects of this mutation on the 
structure and function of DJ-1 were determined with the goal of providing insights into 
the molecular basis of its pathogenicity. 
DJ-1 has been reported to act as a glyoxalase that catalyses the breakdown of reactive α-
oxoaldehyde species e.g. glyoxal and methylglyoxal (Lee et al., 2012). The adjacency 
of the A107P mutation to the active site residue Cys-106 prompted us to investigate the 
effects of this mutation on the ability of DJ-1 to act as a glyoxalase. We found that the 
introduction of the A107P mutation in DJ-1 abrogates glyoxalase activity. Additionally, 
the A107P variant was not capable of protecting cells against glyoxal cytotoxicity and 
the accumulation of CML, an advanced glycation end product.  
A107P occurs in the nucleophile elbow motif, a structural element that lies within the 
glyoxalase active site of DJ-1. This motif positions the cysteine nucleophile, Cys-106, 
in a sharp turn induced by unfavourable backbone torsion angles (Ollis et al., 1992; 
Nardini and Dijkstra, 1999). Our in silico analysis suggests that the A107P mutation 
does not affect significantly the backbone conformation of Cys-106 and hence cannot 
explain the lack of glyoxalase activity. The nucleophile elbow also contains residues 
that promote nucleophilic attack (Nardini and Dijkstra, 1999). Specifically, the motif 
participates in the stabilisation of an oxyanion transition state that forms during a 
nucleophilic attack. To determine the contribution of Ala-107 in the catalysis, we 
sought to capture a snapshot of DJ-1 engaged with a substrate and/or in a nucleophilic 
attack. Our attempts to introduce the substrate, methylglyoxal, into the active site of DJ-
1 have failed. Nevertheless, we solved a crystal structure of the C106S variant bound to 
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glycerol and sulphate in the active site. The position of the sulphate ion makes it a good 
representation of the proposed tetrahedral intermediate that forms during the 
nucleophilic attack. Sulphate ions have been found to occupy oxyanion holes (Molgaard 
et al., 2000; Wang et al., 2002; Tanaka et al., 2010). In our structure, the sulphate 
oxyanion is hydrogen bonded to the amide groups of Ala-107 and Gly-75 forming a 
putative oxyanion hole. The stabilisation of the oxyanion intermediate governs the 
catalytic efficiency of a number of enzymes. Mutations that abrogate the formation of 
oxyanion holes negatively affect catalysis (Bryan et al., 1986; Ordentlich et al., 1998). 
Proline substitution of Ala-107 removes a backbone amide hydrogen and renders the 
protein incapable of stabilising an oxyanion intermediate. For this reason, the A107P 
mutation may impair the glyoxalase activity of DJ-1. However, the effects of the A107P 
mutation extend beyond enzymatic catalysis. 
Early indications of alterations in the structure and the stability of the A107P variant 
were observed during the preparation of the recombinant protein. The reduced amount 
of protein retrieved from the heterologous expression of DJ-1
A107
 was indicative of a 
destabilising effect caused by the mutation. Moreover, the apparent increase in the 
molecular size of the A107P variant estimated using size exclusion chromatography is 
not consistent with homodimerisation but suggested an altered conformational state of 
DJ-1
A107P
 accompanied by an increase in effective hydrodynamic radius, a phenomenon 
observed for a number of unfolded and intrinsically disordered proteins (Batas et al., 
1997; Burre et al., 2013). 
The reduction in protein stability was not immediately apparent in eukaryotic cells. In 
the human cell line SH-SY5Y, the protein level of DJ-1
A107P 
was comparable to the 
wild-type protein. Yet our collaborators have shown a slightly reduced DJ-1
A107P 
level 
in HEK 293E cells. Intuitively, the presence of endogenous wild-type protein may 
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stabilise the mutant protein through heterodimerisation. Neither MEF DJ-1
+/+
 nor MEF 
DJ-1
-/-
 retained a significant amount of the mutant protein, explaining the weak 
immunofluorescent dectection of ectopically expressed DJ-1
A107P
 in MEF DJ-1
-/-
. These 
results suggest that the intracellular steady state level of DJ-1
A107P
 may be cell type-
specific and is not determined by the presence of endogenous wild-type protein. Since 
the constructs used were not identical i.e. different location and type of tag we cannot 
rule out the possibility of the effects of the fused tags in terms of intracellular protein 
concentration and decay.  
The reduced intracellular protein level of DJ-1
A107P
 in HEK 293E and MEF cell lines 
has led to us to investigate the structural effects of the A107P mutation. We first 
compared the secondary structure content of the wild-type protein and DJ-1
A107P
 using 
CD spectroscopy. Proteins, being optically active macromolecules, interact with 
circularly polarised light. Each type of secondary structure absorbs circularly polarised 
light to a different extent, which makes CD spectroscopy a useful tool in analysing 
gross changes in protein structure. The CD spectrum of wild-type DJ-1 represented a 
well-folded protein with calculated secondary structure content consistent with the 
crystal structure. In contrast, the CD spectrum of DJ-1
A107P
 showed an apparent loss of 
α-helical content, indicating global changes in protein structure. NMR spectroscopy was 
used to characterise further the structural defect caused by the A107P mutation. The 
HSQC spectrum of the DJ-1
A107P
 immediately indicated protein misfolding reminiscent 
of the L166P mutation (Malgieri et al., 2008). The structural integrity of the active site 
was greatly compromised as shown by the overlay of the wild-type DJ-1 and DJ-1
A107P
 
HSQC spectra (Figure 37). This provides a molecular explanation for the lack 
glyoxalase activity caused by the A107P mutation. Although we couldn’t exactly map 
the location of the structural perturbations, both CD and NMR data suggested the 
retention of some structures in spite of the remarkable misfolding of the mutant protein. 
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The retained structures perhaps enable the heterodimerisation with wild-type DJ-1 but 
are not sufficient for self-association hence the lack of mutant homodimers observed by 
our Tuebingen collaborators. With reference to the crystal structure of DJ-1 (Tao and 
Tong, 2003), Ala-107 does not contribute directly to homodimer contacts. Hence, the 
loss of mutant homodimerisation suggests that the structural effects of the A107P 
mutation extend beyond local perturbations, disrupting critical points of contact 
between the mutant polypeptides. 
The remarkable misfolding of DJ-1
A107P
 also explains its lack of nuclear translocation. 
DJ-1 translocation into the nucleus requires the SUMOylation of Lys-130. This residue 
is evidently perturbed in the HSQC spectrum of the mutant protein (Figure 37). The 
absence of properly-folded DJ-1 in the nucleus would render it incapable of controlling 
its associated transcription factors such as AR and p53. 
In essence, the A107P mutation in DJ-1 devoids the cell of a multifunctional 
cytoprotective protein that can rescue neuronal cells from progressive degeneration.  
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Figure 37. Overlay of the 
1
H-
15
N HSQC spectra of wild-type DJ-1 and DJ-1
A107P
. 
The proton-nitrogen correlation NMR spectra of wild-type DJ-1 and DJ-1
A107P
 are 
shown in blue and red, respectively. Positions of resonance peaks for Cys-106 and Lys-
130 in the wild-type protein spectrum are indicated by arrows. The NMR data was 
collected by Altin Sula (Birkbeck/UCL) under the supervision of Dr. Mark Williams 
(Birkbeck/UCL). 
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4.1 Biological role of the copper binding site 
The nature of ligation provides clues on the biological function of a copper binding site 
in a protein (Roat-Malone, 2007; Davis and O’Halloran, 2008; Boal and Rosenzweig, 
2009). Proteins involved in enzymatic catalysis, dioxygen transport, and electron 
transfer bind Cu(II) via O-carboxylates (aspartate, glutamate) and N-imidazoles 
(histidine). Proteins involved in copper transport and homeostasis commonly interact 
with Cu(I) using S-thiolates (cysteines) and S-thioethers (methionines). 
The biscysteinate copper binding site of DJ-1 closely resembles that of many copper 
chaperones that possess the sequence motif CXXC or CXC (Davis and O’Halloran, 
2008; Boal and Rosenzweig, 2009). Uniquely, the copper binding site of DJ-1 is formed 
through pseudo 2-fold symmetry related Cys-53, conserved across vertebrates. The 
solvent exposed, docking accessible location of the copper binding site makes DJ-1 a 
good copper donor and/or acceptor. Prompted by the previous work of Xu et al. (2010), 
we tested the ability of DJ-1 to transport copper to SOD1. In our hands, we found no 
stimulation of SOD1 activity by copper-loaded recombinant DJ-1 in vitro. Similarly, 
our collaborators tested the copper chaperone activity of DJ-1 for SOD1 using a 
different method and found no evidence of copper transport. The stimulation of SOD1 
by DJ-1 described by Xu et al. (2010) may have resulted from a fortitious binding of 
copper to the His6 tag, which was not used in the our assays, resulting in nonspecific 
copper acquisition by SOD1. The absence of interaction between DJ-1 and SOD1, 
perhaps due to a lack of a SOD1-interacting domain similar to CCS (Lamb et al., 1999; 
Lamb et al., 2001), may also explain the inability of DJ-1 to specifically deliver the 
copper to SOD1. Nonetheless, because of its chemical features, the copper binding site 
of DJ-1 remains competent for copper transfer to a target protein that is yet to be 
identified. With a coordination number of 2, the biscysteinate site of DJ-1 is capable of 
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engaging in higher-order complexes potentially a tri-coordinate complex that serves as a 
common mechanism for copper transfer used by copper chaperones (Banci et al., 2006). 
Alternatively, DJ-1 could be involved in the homeostatic control of copper by means of 
direct metal sequestration and/or trafficking of copper out of the cell. Chronic 
occupational exposure to copper has been linked to an increased risk of developing 
Parkinson’s disease (Gorell et al., 1997; Willis et al., 2010). Free copper ions can 
promote neurodegeneration by damaging proteins, nucleic acids, and lipids (Halliwell 
and Gutteridge, 1990). Specifically, copper has been shown to accelerate the formation 
of cytotoxic oligomers of α-synuclein, a protein linked to autosomal dominant, familial 
Parkinson’s disease (Wright et al., 2009). The complex of copper with α-synuclein can 
also induce the generation of reactive oxygen species (Paik, et al., 1999; Wang et al., 
2010). Therefore, DJ-1, through its ability to sequester copper, could prevent copper’s 
deleterious interactions with cellular components. Additionally, DJ-1 can potentially aid 
in the removal of copper from the intracellular milieu via its secretion out of the cell 
(Tsuboi et al., 2008). The proposed biological functions of the copper binding site are 
depicted in Figure 38. 
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Figure 38. Proposed biological roles of the copper binding site of DJ-1. 
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4.2 Structure of Cu(I)-bound DJ-1 establishes the role for DJ-1 homodimerisation 
in copper sequestration: insights into mutational inactivation of DJ-1 in PD 
The structure of DJ-1 complexed with a Cu(I) ion reveals the requirement for a stable 
homodimer in order to function as a copper carrier. This is supported by the fact that 
DJ-1 mutations A104T and D149A, which have been reported to reduce DJ-1 
homodimerisation (Moore et al., 2005), abrogated the ability of DJ-1 to confer 
cytoprotection against copper- and mercury- induced cell death (Bjokblom et al., 2013). 
The structural basis on how these mutations affect DJ-1 homodimerisation awaits 
further investigation. Nonetheless, the A104T mutation has been shown to destabilise 
the DJ-1 fold by introducing a polar residue in the hydrophobic core 
(Lakshminarasimhan et al., 2008) which can potentially lead to weakened interactions 
between the monomers.   
Several other mutations in DJ-1 have been shown to decrease homodimerisation and/or 
reduce the intracellular levels of the protein (Figure 39; Moore et al., 2003; Gorner et al., 
2007; Hulleman et al., 2007; Lakshminarasimhan et al., 2008). The mutation L166P 
completely impairs dimerisation and is rapidly degraded in mammalian cells (Moore et 
al., 2003; Hulleman et al., 2007). L166P disrupts helix G found in the C-terminal helix-
kink-helix motif resulting in the destabilisation of the DJ-1 dimer (Gorner et al., 2007). 
Another mutation M26I, which resides in helix A, causes a subtle change in the core of 
the dimer, forming a cavity that results in inefficient packing (Lakshminarasimhan et al., 
2008). M26I has been shown to reduce the extent of dimerisation in vitro (Hulleman et 
al., 2007) and in vivo (Repici et al., 2013). A charge reversal mutation E163K has been 
identified from a patient manifesting parkinsonism with dementia and amyotrophic 
lateral sclerosis (Annesi et al., 2005). E163K abolishes a salt bridge between Glu-163 
and Arg-145, which further participates in a hydrogen bond network that spans across 
the dimer interface, therefore weakening the homodimer interactions 
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(Lakshminarasimhan et al., 2008). The L10P and L158del mutations have also been 
shown to impair DJ-1 homodimerisation albeit no details have been reported on how 
these mutations affect the oligomeric state of DJ-1 (Rannikko et al., 2013; Repici et al., 
2013). These aforementioned mutations that lead to loss of homodimerisation and 
protein stability would potentially impair the ability of DJ-1 to protect against metal-
induced cellular degeneration. 
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Figure 39. Location of Parkinsonism-linked mutations that reduce DJ-1 
dimerisation. The mutation M26I, which lies in helix αA, results in a packing defect in 
the core of the dimer. Two mutations in helix αG, L166P and E163K, also result in 
weakening of dimer interactions. The positions of the L10P, A104T, D149A and 
L158del mutations are also shown. Structure of DJ-1 (PDB ID code: 4BTE) was 
rendered using PyMol (Delano, 2002). 
 
104 
 
4.3 Molecular basis for the pathogenicity of the DJ-1 A107P mutation 
In Chapter 3, we have characterised the pathogenic effects of the A107P mutation on 
the structure and function of DJ-1. Firstly we have shown that DJ-1
A107P
 lacks 
glyoxalase activity in vitro which correlated with the loss of protection against glyoxal 
cytotoxicity and increased CML damage to cellular proteins. α-Oxoaldehydes are by-
products of metabolism (Phillips and Thornalley, 1993). Their accumulation contributes 
to pathological processes associated with neurodegeneration including proteasomal 
inhibition (Bento et al., 2010; Queisser et al., 2010), mitochondrial dysfunction (Wang 
et al., 2009), protein aggregation (Shaikh and Nicholson, 2008), and oxidative stress 
(Ramasamy et al., 2005; Ramasamy  et al., 2006; Kuntz et al., 2010). Hence the cell 
employs multiple systems to eliminate α-oxoaldehydes. Although the glutathione-
dependent GLO1/GLO2 system plays a major role in protecting cells against α-
oxoaldehyde-induced damage, DJ-1’s ability to catalyze the detoxification of α-
oxoaldehyde in the absence of a glutathione cofactor poses an advantage when cellular 
glutathione levels are depleted (Lee et al., 2012). One of the pathological features of 
neurons affected in PD is the significant decrease in the cellular glutathione 
concentration (Perry et al., 1982). Intuitively, in such pathological event, the absence of 
DJ-1 glyoxalase activity can lead to a deleterious accumulation of α-oxoaldehyde. 
Secondly we and our collaborators have shown that the A107P mutation affects the 
intracellular steady state levels and the oligomeric state of the DJ-1 protein. In our 
hands, the protein levels of wild-type DJ-1 and DJ-1
A107P
 showed no apparent difference. 
But when our Tuebingen collaborators compared the intracellular steady-state levels of 
the wild-type protein and DJ-1
A107P
 they found a decrease in the levels of DJ-1
A107P
 
relative to the wild-type protein albeit in different cell lines, HEK 293E and MEF. The 
difference may be due to the effects of the tags used in the experiments however Gorner 
et al., (2007) have shown that the type and the position of the tag does not dictate the 
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intracellular concentration of the wild-type protein relative to variants with the same tag. 
Hence, it is possible that the effects of the mutation is cell-type specific. Nonetheless, 
the rate of protein turnover should also be investigated to ascertain the inherent stability 
of the various constructs in different cell lines. Similar effect on intracellular steady-
state levels has been demonstrated for a number of PD-linked DJ-1 mutations e.g. L10P, 
L158del, and L166P (Moore et al., 2003; Gorner et al., 2004; Olzmann et al., 2004; 
Blackinton et al., 2005; Ramsey and Giasson, 2010; Rannikko et al., 2012). Expression 
of the A107P variant does not affect the levels of endogenous wild-type DJ-1, 
consistent with the recessive nature of the mutation. 
Using NMR and CD spectroscopy we have shown that the DJ-1
A107P
 exhibits 
remarkable degree of misfolding, providing a molecular basis for the lack of glyoxalase 
activity, the absence of nuclear translocation, and the decrease in intracellular protein 
levels. The structural and biochemical properties of DJ-1
A107P
 recapitulate those of the 
L166P mutant. However unlike the L166P mutant, DJ-1
A107P
 is capable of 
heterodimerisation with wild-type DJ-1 (Olzmann et al., 2004). In addition, HEK 293E 
expressed DJ-1
A107P
 does not exhibit proteolytic breakdown products which are 
observed for ectopically expressed L166P mutant (Olzmann et al., 2004). This suggests 
that the structural defect caused by the A107P mutation is distinct from the L166P 
mutant. Nevertheless, both mutations lead to a loss of a multifunctional protein that aids 
in cellular protection against cellular degeneration.  
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4.5 Role of the nucleophile elbow motif in the structural integrity of the DJ-1 fold 
Our structural characterisation of the A107P mutation in human DJ-1 highlights the role 
for the nonenzymatic residues of the nucleophile elbow motif not only in the molecular 
architecture of the active site but also in the proper folding of the DJ-1 polypeptide.  
The nucleophile elbow motif, first described in α/β-hydrolases, is a conserved structural 
feature among DJ-1 homologues. This motif uniquely positions the nucleophilic residue, 
Cys-106 in the case of human DJ-1, in a sharp turn imposed by constrained backbone 
torsion angles (φ = 66°, ψ = -117° in human DJ-1). The motif is identified by the 
consensus sequence Sm-X-Nu-X-Sm where Sm = small residue, Nu = nucleophile, and 
X = any residue. The requirement for residues with small side chains at positions Nu-2 
and Nu+2 arises from the fact that these residues are very close to each other, thus in 
order to prevent steric clash, either of these positions are usually occupied by an alanine 
or a glycine residue (Ollis et al., 1992). In human DJ-1, the Cα of Ala-105 and Gly-108 
are separated by a distance of 5Å (Figure 40A). Moreover, the side chains of Nu-2 and 
Nu+2 are pointed towards the hydrophobic core of the protein (Figure 40B), hence, a 
nonpolar residue usually occupies these positions (Figure 26). Indeed, substitution of 
Ala-104 in human DJ-1 for a polar and relatively larger threonine residue causes local 
structural perturbation of the hydrophobic core (Lakshminarasimhan et al., 2008). The 
A104T mutation also recruits a water molecule into the hydrophobic core, further 
destabilising the fold (Lakshminarasimhan et al., 2008). Unsurprisingly, the A104T 
mutation was isolated from a patient with early-onset Parkinsonism (Hague et al., 2003). 
It was previously thought that the position Nu+1 could be occupied by any amino acids. 
In this study, we have shown that proline substitution of Ala-107 (Nu+1 in human DJ-1) 
results in a remarkable misfolding of the DJ-1 protein. Hence, to maintain proper 
folding at least in DJ-1 homologues, the residue at position Nu+1 should be a 
nonproline residue. Close inspection of this residue in the structure of human DJ-1 does 
107 
 
not show any obvious steric hindrance or disruption of interactions when substituted by 
proline. Perhaps, the slight change in backbone torsion angles predicted in silico is 
translated into a more profound structural perturbation of the fold. Another possibility is 
the disruption of a quasi-helical conformation, conserved among DJ-1 homologues, 
succeeding the elbow turn (Figure 40C).  Further investigation is necessary to ascertain 
the exact structural basis by which the A107P disrupts the DJ-1 fold. 
We surmise that the nucleophile elbow motif is also involved in critical interactions that 
anchor the fold together. A sequence alignment of DJ-1 homologues reveals two highly 
conserved sequence motifs that interact with the nucleophile elbow (Figure 41A). The 
two motifs exhibit a strand-loop-helix topology (Figure 41B). Motif I interacts with the 
nucleophile elbow via main-chain hydrogen bonding between Leu-72 and Ile-105 while 
the Ser-155 main-chain amide donates a hydrogen bond to the main-chain amides of Ile-
105 and Ala-104 (Figure 41C). Disruption of these interactions by disease-linked point 
mutations is predicted to cause a deleterious effect on the proper folding of DJ-1.  
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Figure 40. Structure of the human DJ-1 nucleophile elbow motif. (A) The DJ-1 
structure (PDB ID code: 1PDV) is shown as a cartoon with the residues in the 
nucleophile elbow as sticks and the distance between the Cα of Ala-104 and Gly-108 is 
indicated in Angstroms. (B) Cartoon representation of human DJ-1 with the 
transparency increased to 80% to show the side chains of Ala-104 and Gly-108 pointing 
to the hydrophobic core of the protein. (C) Helical conformation of the residues 
succeeding the nucleophilic residue in DJ-1 homologues. Backbone traces (right panel) 
and cartoon representations (left panel) of the nucleophile elbow motifs in various DJ-1 
homologues are shown with the side chain of the nucleophilic residue as sticks. 
Structures were rendered using PyMol (Delano, 2002). 
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Figure 41. Conserved motifs interacting with the nucleophile elbow motif in DJ-1. 
(A) Multiple sequence alignment showing the conservation of two strand-loop-helix 
regions in prokaryotic and eukaryotic homologues of DJ-1. Motifs I and III are 
highlighted in cyan and yellow, respectively. The nucleophile elbow motif (motif II) is 
highlighted in magenta. Uniprot accession numbers are shown in parentheses. (B) 
Positions of motifs I, II, III in the crystal structure of DJ-1 (PDB ID code: 1PDV). (C) 
Interaction between the residues of the nucleophile elbow motif (motif II) and residues in motif 
I and III. Structures were rendered using PyMol (Delano, 2002). 
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4.4 Crystal structure of DJ-1 C106S bound to a sulphate anion and glycerol 
illuminates the mechanism of substrate recruitment and hemithioacetal 
intermediate formation  
The initial step in the glyoxalase reaction mechanism of DJ-1 involves a nucleophilic 
addition reaction whereby the S-thiolate moiety of Cys-106 attacks the aldehydic 
carbonyl carbon (C1) of the α-oxoaldehyde e.g. methylglyoxal, giving rise to a 
hemithioacetal (Kwon et al., 2013). The crystal structure of the DJ-1 C106S variant 
bound to a sulphate anion and glycerol in the active site provides molecular clues on 
how this initial step takes place (Figure 42). We found glycerol to be hydrogen bonded 
to the side chain of Arg-28’ (of subunit B). I posit that glycerol mimics an α-
oxoaldehyde being recruited by Arg-28’ into the active site. Unlike glycerol with sp3 
hybridised carbons, the α-oxoaldehyde carbons are sp2 hybridised and therefore would 
be coplanar with Arg-28’ sidechain guanidium moiety. This positions the substrate to an 
orientation favourable for nucleophilic attack. Arg-28’ is anchored to subunit A via 
guanidium stacking with Arg-48 (Witt et al., 2008). I envision that these two highly 
conserved arginine residues work together to guide the substrate into the active site. 
Consequently, homodimerisation is required to create a substrate recruitment site. PD-
linked mutations that impair DJ-1 dimerisation could therefore affect the ability of DJ-1 
to detoxify α-oxoaldehydes.  
Thus far, I have produced a recombinant DJ-1 with an R28Q mutation to test the crucial 
role of this residue in substrate recruitment and catalysis. This mutation has been chosen 
over R28A because it has been shown to retain dimerisation and does not affect the pKa 
of Cys-106 (Herrera et al., 2007; Witt et al., 2008), hence avoiding a compounding 
effect. I posit that this mutation will reduce the ability of DJ-1 to catalyse glyoxal 
detoxification. However, the R28Q mutant exhibits a catalytic turnover constant similar 
to the catalytically inactive C106S mutant (Figure 43). This suggests that Arg-28’ may 
play catalytic roles other than substrate recruitment and optimal orientation of the 
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substrate for nucleophilic addition reaction. Interaction of Arg-28’ guanidinium group 
may increase the dipole moment of the α-oxoaldehyde substrate thereby further 
activating the aldehydic carbon for nucleophilic attack. Additionally, I have also shown 
that aspartic acid substitution of Glu-18 does not support catalysis (Figure 43), 
consistent with a previous report (Lee et al., 2012) 
When Cys-106 attacks the aldehydic carbonyl carbon of the α-oxoaldehyde, a 
tetrahedral transition state will form with an oxyanion moiety. The stabilisation of the 
oxyanion influences the efficiency of the reaction in many enzymes (Byran et al., 1986; 
Menard and Storer, 1992; Li et al., 2000; Lee et al., 2006). Dedicated residues within 
the active site form an oxyanion hole to stabilise the transition state. Sulphate, a 
monomeric oxyanion, occupied the active site pocket in the crystal structure. The 
sulphate oxyanion was mainly held by the amide NH moieties of Gly-75 and Ala-107 
(Figure 42). I envision that the sulphate ion mimics the tetrahedral transition state 
during nucleophilic addition with the backbone amide NH of Gly-75 and Ala-107 
forming an oxyanion hole. Gly-75 and Ala-107 are highly conserved residues in DJ-1 
homologues. The role of Ala-107 in forming an oxyanion hole is supported by a report 
of Buller and Townsend (2013) on the geometric rules governing the reaction 
mechanism of enzymes with a nucleophile elbow.  
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Figure 42. Proposed mechanism of the hemithioacetal intermediate formation of 
the DJ-1 glyoxalase reaction. Reaction mechanism (left panel) of the nucleophilic 
addition step of DJ-1 glyoxalase. The glycerol and sulphate in the active site mimic the 
substrate and transition state, respectively (right panel). Cartoon representations of 
subunits A and B of the DJ-1 homodimer are coloured green and magenta, respectively. 
Structures were rendered using PyMol (Delano, 2002). 
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Figure 43. Glyoxalase catalytic turnover constants of DJ-1 variants. kcat values were 
estimated using a DNPH-based quantitative assay using glyoxal as substrate. Data are 
presented as mean ± SEM obtained from data (n = 3) from three repeats. (*) denotes p < 
0.0001 in an unpaired t-test when compared with the kcat values of the wild-type protein. 
*                *                 * 
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4.5 Future work 
The results presented in this thesis point to several research opportunities to advance our 
molecular understanding of the multifaceted cellular function of DJ-1. The following 
future directions for further work are recommended: 
 
Can DJ-1 prevent α-synuclein aggregation induced by copper? 
α-Synuclein aggregation has been linked to the development of PD (Conway et al., 
1998; Eriksen et al., 2005). Copper accelerates the formation of neurotoxic oligomers of 
α-synuclein (Wright et al., 2009). It therefore raises question of whether DJ-1, through 
its subfemtomolar affinity for copper, is capable of sequestering the copper from α-
synuclein. DJ-1 has already been shown to inhibit the inherent ability of α-synuclein to 
aggregate (Shendelman et al., 2004; Zhou et al., 2006). It would be interesting to test 
whether DJ-1 can also protect against accelerated α-synuclein aggregation induced by 
copper in vivo and whether mutations that disrupt the copper binding site perturb such 
capability. 
 
How does copper binding affect the glyoxalase activity of DJ-1? 
The copper binding site and the glyoxalase active site are found in distinct locations in 
DJ-1. This exemplifies the multifaceted nature of the cellular function of DJ-1. Yet it 
also raises interesting questions on whether the two biological activities are related. 
Does copper binding regulate the ability of DJ-1 to act as a glyoxalase? Perhaps it is 
unlikely given the spatial distance between the two sites. However, the copper site null 
C53A mutant has been suggested to promote Cys-106 oxidation (Waak et al., 2009), 
which would inactivate the glyoxalase activity of DJ-1.  
 
 
115 
 
Reaction mechanism of DJ-1 glyoxalase activity 
So far, our crystal structure of DJ-1 bound to glycerol and sulphate provided molecular 
clues on the mechanism of substrate binding and the initial step of the glyoxalase 
activity of DJ-1. However, a crystal structure of DJ-1 bound to a real substrate and/or 
engaged in catalysis will prove to be invaluable in determining the complete reaction 
mechanism and regioselectivity of insofar the only eukaryal glyoxalase that does not 
require a glutathione cofactor. In prokaryotes, the cofactor-independent glyoxalase 
(Hsp31 in E. coli) converts methylglyoxal into D-lactate (Subedi et al., 2011). It would 
be interesting to know whether the same enantiomer of lactate is produced by human 
DJ-1 given the differences in the architecture of the actives sites between the two 
enzymes.  
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5.1 Bacterial strains 
Table 5. E. coli strains for cloning and protein expression. 
Strain Genotype Source 
TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 nupG recA1 
araD139 Δ(ara-leu)7697 galE15 
galK16 rpsL(Str
R) endA1 λ- 
Life 
Technologies 
BL21 (DE3) F
–
 ompT gal dcm lon hsdSB(rB
-
 mB
-
) 
λ(DE3 [lacI lacUV5-T7 gene 1 ind1 
sam7 nin5]) 
Stratagene 
BL21 (DE3) 
pLysS 
F- ompT hsdSB (rB-mB-) gal dcm 
(DE3) pLysS (CamR) 
Life 
Technologies 
 
5.2 Plasmid constructs and primers 
Table 6. Plasmid constructs. 
Name Vector Insert Tag Cloning 
Sites 
Primers 
DJ-1x pET-28a (+) human DJ-1 - NcoI/XhoI 1, 3 
DJ-1-His6 pET-28a (+) human DJ-1 CT His6 NcoI/XhoI 1, 2 
C53Ax pET-28a (+) DJ-1 C53A  - NcoI/XhoI 5, 6 
C106Sx pET-28a (+) DJ-1 C106S  - NcoI/XhoI 20, 21 
A107P-His6 pET-28a (+) DJ-1 A107P  CT His6 NcoI/XhoI 7, 8 
C106A-His6 pET-28a (+) DJ-1 C106A  CT His6 NcoI/XhoI 9, 10 
SOD1 pLEICS-03 Wild-type 
human SOD1 
NT His6 NcoI/XhoI 11, 12 
HCV pLEICS-03 SOD1 H46F/ 
C146S   
NT His6 NcoI/XhoI 13-16 
pDJ-1-His6 pCDNA 4 human DJ-1 CT His6 BamHI/XhoI 2, 4 
pA107P-His6 pCDNA 4 DJ-1 A107P  CT His6 BamHI/XhoI 2, 4 
pC106A-His6 pCDNA 4 DJ-1 C106A  CT His6 BamHI/XhoI 2, 4 
pDJ-1x pCDNA 4 human DJ-1 - BamHI/XhoI 3, 4 
pC53Ax pCDNA 4 DJ-1 C53A  - BamHI/XhoI 3, 4 
His6-tat-DJ-1 pLEICS-03 human DJ-1  NT His6 NcoI/XhoI 19, 3 
His6-tat-C106A pLEICS-03 DJ-1 C106A  NT His6 NcoI/XhoI 19, 3 
His6-tat-A107P pLEICS-03 DJ-1 A107P NT His6 NcoI/XhoI 19, 3 
 
118 
 
Table 7. Cloning and sequencing primers 
No. Primer Sequence (5’  3’) 
1 DJ-1 FWD ATTCCATGGCTTCCAAAAGAGCTCTGGTCA 
2 DJ-1 REV AATCTCGAGCGTCTTTAAGAACAAGTGGAGCCTT 
3 DJ-1 STOP REV AATCTCGAGTTACGTCTTTAAGAACAAGTGGAGC
CTT 
4 DJ-1 TET FWD ATTCCATGGCTTCCAAAAGAGCTCTGGTCA 
5 DJ-1 C53A FWD ATGTGGTCATTGCACCTGATGCCAG 
6 DJ-1 C53A REV CTGGCATCAGGTGCAATGACCACAT 
7 DJ-1 A107P FWD AGCCGCCATCTGTCCAGGTCCTACTG 
8 DJ-1 A107P REV CAGTAGGACCTGGACAGATGGCGGCT 
9 DJ-1 C106A FWD CCGCCATCGCTGCAGGTCCT 
10 DJ-1 C106A REV AGGACCTGCAGCGATGGCGG 
11 SOD1 FWD AATCCATGGCTTCCAAAAGAGCTCTGGTCA 
12 SOD1 REV ATTCTCGAGTTGGGCGATCCCAATTACA 
13 SOD1 H46F FWD CATGGATTCTTCGTTCATGAGTTTG 
14 SOD1 H46F REV CAAACTCATGAACGAAGAATCCATG 
15 SOD1 C146S FWD GTCGTTTGGCTAGCGGTGTAATTG 
16 SOD1 C146S REV CAATTACACCGCTAGCCAAACGAC 
17 T7 FWD TAATACGACTCACTATAGGG 
18 T7 REV GCTAGTTATTGCTCAGCGG 
19 DJ-1 TAT FWD ATTCCATTGGGCAGGAAGAAGCGGAGACAGCGA
CGAAGAAGAGGCTCGATGGCTTCCAAAACAG 
20 DJ-1 C106S FWD GTAGGACCTGCAGATATCGCGGCTATCAG 
21 DJ-1 C106S REV CTGATAGCCGCGATATCTGCAGGTCCTAC 
 
5.3 Media, buffers, and solutions 
Table 8. Media and media supplements 
Name Composition 
LB broth 1% w/v tryptone, 0.5% w/v yeast extract, 0.5% w/v NaCl  
15
N -M9 medium 42 mM Na2HPO4, 22 mM KH2PO4, 86 mM NaCl, 7.6 mM 
15
(NH4)2SO4, pH adjusted to 7.4 
10X M9 supplement 10 mM MgSO4•7H2O, 10 mM thiamine, 1 mM 
CaCl2•2H2O, 40% w/v glucose, 0.01 mM FeSO4•7H2O 
 
Table 9. Antibiotics 
Name Stock solution Working Concentration 
Ampicillin 200 mg/ml in ddH2O 200 µg/ml 
Kanamycin 50 mg/ml in ddH2O 50 µg/ml 
Chloramphenicol 34 mg/ml in ethanol 34 µg/ml 
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Table 10. General buffers and solutions 
Name Composition 
TSS 10% w/v PEG 8000, 30 mM MgCl2, 5% v/v 
DMSO 
5X TBE 450 mM Tris, 450 mM boric acid, 10 mM EDTA 
10X SDS-PAGE Running Buffer 250 mM Tris, 1% w/v SDS, 2.5 M glycine 
4X SDS-PAGE sample buffer 250 mM Tris pH 6.8, 10 % w/v SDS, 0.008% 
w/v bromophenol blue, 20% v/v 
mercaptoethanol or 1 M DTT, 40% v/v glycerol 
6X Loading dye 10 mM Tris pH 7.6, 0.0015% w/v bromphenol 
blue, 60% v/v glycerol, 100 mM EDTA 
Coomassie stain 40% v/v methanol, 10% v/v glacial acetic acid, 
0.1% Coomassie Brilliant Blue R-250 
Destaining solution 10% v/v methanol, 10% v/v glacial acetic acid 
Transfer Buffer 0.25 M glycine, 25 mM Tris, 20% v/v methanol 
TBS 50 mM Tris pH 7.5, 150 mM NaCl 
TBS-T 50 mM Tris pH 7.5, 150 mM NaCl, 0.05% v/v 
Tween 20 
PBS 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.76 mM KH2PO4, pH adjusted to 7.4 
PBS-T 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.76 mM KH2PO4, pH adjusted to 7.4, 0.1% v/v 
Tween 20 
CD Buffer 20 mM HEPES pH 7.5, 50 mM NaCl 
Microassay buffer 20 mM Tris pH 8.0, 100 mM NaCl 
 
Table 11. Buffers used in protein purification 
Name Composition 
Buffer A 50 mM Tris pH 8.0, 300 mM NaCl 
Buffer B 50 mM Tris pH 8.0, 300 mM NaCl, 25 mM imidazole 
Buffer C 50 mM Tris pH 8.0, 300 mM NaCl, 10 mM imidazole 
Buffer D 50 mM Tris pH 8.0, 300 mM NaCl, 5% v/v glycerol,  
250 mM imidazole 
Buffer E 20 mM Tris pH 8.0, 100 mM NaCl 
Buffer F 20 mM Tris pH 7.15, 100 mM NaCl 
Buffer G 20 mM Tris pH 8.0, 100 mM NaCl, 0.5 mM TCEP 
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5.4 Molecular biology methods 
5.4.1 Preparation of chemically competent cells 
To prepare chemically competent cells, fresh LB broth was inoculated with a starter 
culture grown at 37°C for 18-20 hours. Cells were grown with shaking (250 rpm) at 
37°C until the optical density at 595 nm (OD595) reached 0.4 and then transferred to an 
ice bath to chill for 10 minutes. Cells were centrifuged at 3000 x g and gently 
resuspended in TSS buffer. The resuspended cells were further incubated on ice for at 
least 20 minutes prior to distribution and storage at -80°C. 
5.4.2 Transformation of chemically competent cells 
Plasmid DNA (10 ng) was incubated with an aliquot of thawed competent cells on ice 
for at least 5 minutes. Cells were heat-shock at 42°C for 45 seconds and subsequently 
incubated on ice for another 5 minutes. LB broth (400 µl per 50-100 µl cells) was added 
to the cells and incubated with shaking (180 rpm) at 37°C for an hour. Transformed 
cells were either grown directly in LB broth or agar plates supplemented with 
antibiotics as appropriate. 
5.4.3 Agarose gel electrophoresis 
TBE was used as the buffer system for agarose gel electrophoresis. Agarose gels were 
prepared using electrophoresis-grade agarose (Sigma) dissolved in 0.5X TBE. Prior to 
casting, ethidium bromide (1 ug/ml) was usually added to the gel solution. Samples 
were prepared by mixing DNA solutions with the loading dye (Qiagen). Electrophoresis 
was carried out in a Bio-Rad Mini-Sub Gel GT with the gel submerged in 0.5X TBE. 
Gels were visualised using a UVP transilluminator. 
5.4.4 Molecular cloning 
Wild-type human DJ-1 and human SOD1 pET-28a clones used as templates for cloning 
were a kind gift of Prof. Simon Moller (St. John’s University, USA). Polymerase chain 
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reaction (PCR) was used to amplify the coding sequence of the gene of interests. 
Primers were designed with a 5’ overhang followed by a restriction site and around 17-
25 nucleotides complementary to the gene of interest. Occasionally, additional 
nucleotide sequences e.g. tat domain were added before the gene sequences. 
Lyophilised primers (~50 nmol) were dissolved in ddH2O and were used at 25-50 pmol 
per reaction. Reaction mixtures were prepared using a ready-to-use PCR master mix 
(Promega) that utilises the Taq DNA polymerase to amplify the target sequence. 
Reactions were carried out using BioRad MJ Mini thermal cycler. The thermocycler 
programs used were customised for each target sequence. Purification of the amplified 
DNA was performed using the QIAquick PCR purification protocol (Qiagen). 
To create the sticky ends of the target sequence, hereafter will be referred to as insert, 
purified PCR products were cut using restriction enzymes (New England Biolabs) 
following the manufacturer’s protocol. Reactions were carried out for at least 2 hours. 
Digested products were purified using the QIAquick gel extraction kit (Qiagen). 
Plasmid vectors were digested using the same procedure. 
Ligation was performed by incubating the mixture of linearised plasmid vector (10 
ng/µl) and digested insert DNA (30 ng/µl or more) with T4 DNA ligase (New England 
Biolabs) for 1 hour at 16°C. Ligation products were transformed into TOP10 (Life 
Technologies) as described in Section 5.4.2. 
To determine a positive colony i.e. colony that contains a plasmid vector with the insert 
DNA, PCR reaction mixtures containing sequencing primers were inoculated with the 
bacterial colony and then a PCR was carried out. Empty vector was used as negative 
control. PCR products were analysed for the presence of insert using agarose gel 
electrophoresis. Positive clones were propagated using a plasmid miniprep kit (Qiagen) 
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and the accuracy of the sequence was determined using the UCL DNA sequencing 
service. 
Point mutations were introduced using the QuikChange (Stratagene) protocol. Codon 
changes were made in the primers that were used to amplify the entire plasmid 
constructs. Parent vector DNA was removed from the PCR product by treatment with 
DpnI (New England Biolabs). Subsequently, the PCR-generated mutant constructs were 
propagated into TOP10 and and the accuracy of the sequence was determined using the 
UCL DNA sequencing service. 
5.5 Protein production and analysis 
5.5.1 Recombinant DJ-1 production in E. coli (applies to all DJ-1 constructs) 
A day prior to protein expression, E. coli BL21(DE3) cells were transformed with the 
plasmid DNA. The transformed cells were grown in 50-ml LB broth supplemented with 
the selective antibiotics at 37°C overnight. The overnight cultures were then used to 
inoculate (4 ml culture per 400 ml fresh broth) LB broth containing appropriate 
antibiotics. When the OD595 of the bacterial culture reached 0.6-0.7, IPTG was added to 
each broth to a final concentration of 0.4 mM and the cultures were further incubated 
for 4 hours to allow protein expression. Cells were harvested by centrifugation and 
resuspended in Buffer A. Cells were frozen at -80°C at this stage until protein extraction 
could be performed. 
5.5.2 Preparation of 
15
N-labelled DJ-1 proteins 
E. coli BL21(DE3) cells transformed with the DJ-1 pET-28a constructs were grown 
overnight (not more than 18 hours) in LB broth containing kanamycin at 37°C with 
shaking (200 rpm). The overnight culture was used to inoculate the pre-warmed 
15
N-M9 
media with supplements and kanamycin; 4 ml overnight culture per 400 ml M9 media. 
The cells were allowed to grow at 37°C with shaking until the OD595 reached 0.6-0.8 
123 
 
and then the cultures were cooled to 25°C for at least 30 minutes. IPTG was added to a 
final concentration of 0.2 mM. Cultures were incubated overnight at 25°C with shaking 
(200 rpm) prior to harvesting. Uniformly 
15
N-labelled proteins were purified using the 
same procedure as the non-labelled proteins. 
5.5.3 DJ-1 protein extraction and purification (applies to all DJ-1 constructs) 
To extract proteins, cells were lysed with a combination of lysozyme treatment (1 
mg/ml) and 2 freeze-thaw cycles followed by sonication. The cell lysates were then 
clarified by ultracentrifugation (20 000 x g for 1 hour at 4°C). 
For His6-tagged constructs, the cleared cell lysates were loaded onto either Ni
2+ 
(Qiagen) 
or Co
2+
 (HisPur, Pierce) affinity resins. Ni
2+
 affinity resin was preferred for pLEICS-03 
derived constructs. Protein-loaded resin was washed with 100 column volumes of 
Buffer B for Ni
2+
 affinity resin or Buffer C for Co
2+
 affinity resin. Finally proteins were 
eluted with 5 column volumes of Buffer D. 
Untagged DJ-1 was purified according to a method previously described (Zhou et al., 
2006). Briefly, ammonium sulphate was added to the cleared lysate to 60% saturation 
and the resulting precipitates were removed by centrifugation. The soluble fraction was 
applied to a phenyl-sepharose column (GE Healthcare) and fractionated by decreasing 
ammonium sulphate saturation. Ammonium sulphate solutions were buffered with 20 
mM Tris pH 8.0. Samples of each fraction were profiled by SDS-PAGE using 
Coomassie R-250 as a stain. Fractions containing untagged DJ-1 were pooled and 
exchanged into Buffer E using a PD-10 column (GE Healthcare). When necessary, 
proteins were subjected to anion exchange chromatography using Q-sepharose (GE 
Healthcare) and/or size exclusion chromatography (SEC) using Sephacryl S-100 (GE 
Healthcare). Buffer F was used as the mobile phase for the SEC procedure. 
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5.5.4 Preparation of apo-SOD1 and variants 
Using the Protex cloning service in Leicester, human SOD1 was cloned into the 
pLEICS-03 vector to generate a recombinant plasmid expressing a protein with a 
tobacco etch virus (TEV) protease cleavable N-terminal His6 tag. His6 tagged SOD1 
was expressed in BL21(DE3) cotransformed with pLysS plasmid (Novagen) to improve 
the yield of soluble proteins. Cells were grown in LB media supplemented with 
kanamycin and chloramphenicol to an absorbance at 595 nm of 0.5-0.7, induced with 
0.4 mM IPTG, and incubated for 4 hours at 37°C before harvesting. Cells were lysed 
with a combination of lysozyme treatment (1 mg/ml) and 1-2 freeze-thaw cycle(s) 
followed by sonication. The cell lysates were cleared by ultracentrifugation at 20 000 x 
g for 1 hour at 4°C. His6 tagged SOD1 was purified using HisPur cobalt(II)-affinity 
resin (Pierce) according to the protocol described in Section 5.5.3. To remove the tag, 
the HisPur eluate was buffer exchanged into Buffer G and then treated with GST-TEV 
protease (100 µg enzyme per 1 mg of protein; Protex, Department of Biochemistry, 
University of Leicester) overnight.  
Apo-SOD1 was prepared as follows. Recombinant SOD1 was treated with 20 mM DTT 
for 10 minutes and acidified by adding 0.4% v/v Trifluoroacetic acid (Sigma) for 30 
minutes on ice. The following reagents were then sequentially added: 10% v/v methanol 
and 15% v/v acetonitrile, 1 mM bathocuproine disulphonate (Sigma) and 1 mM EDTA. 
The reaction mixture was incubated for 3 hours at 4°C. Finally, the protein was buffer-
exchanged into Buffer E using PD-10 chromatography. 
5.5.5 Determination of protein concentration 
A Bradford microassay (Bio-Rad) was used to quantify the protein concentration. BSA 
(Pierce) was used as a protein standard. Each protein sample was diluted in Microassay 
buffer to make up an 800 µl solution. To each sample, 200 µl of Bradford reagent 
concentrate (Bio-Rad) was added and incubated for at least 5 minutes at room 
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temperature. Absorbance was measured at 595 nm using a benchtop spectrophotometer. 
Standard curves (absorbance versus concentration, µg/ml) were plotted in Microsoft 
Excel 2007 and the equation of the line was used to calculate the concentration of each 
protein sample. 
5.5.6 SDS-PAGE 
SDS-PAGE was performed using the Laemmli buffer system (Laemmli, 1970). Each 
resolving gel used was adjusted to 12% v/v acrylamide using 30% w/v 
acrylamide:bisacrylamide (37.5:1) (National Diagnostics).  Each protein sample was 
mixed with SDS-PAGE sample buffer and heated at 95°C for 5 minutes. Protein gels 
were electrophoresed using the Bio-Rad Mini Gel tanks filled with 1X SDS-PAGE 
running buffer at 180 V for 1 hour. Gels were boiled in Coomassie stain for a minute 
and then incubated in the destaining solution until protein bands appeared against a 
clear background. 
5.6 Chemical and biophysical techniques 
5.6.1 Electronic absorption spectroscopy 
All solutions were prepared in an anaerobic glove box at room temperature. Untagged 
DJ-1 was pre-treated with DTT to reduce disulphide bonds and with EDTA to remove 
any bound metal ions. The reduced apoprotein was buffer exchanged into a degassed 
solution containing 25 mM Tris pH 7.5, 100 mM NaCl. The protein solution (10 µM 
dimer) was transferred to a sealed cuvette and titrated with a Cu(I) solution prepared by 
dissolving [Cu(CH3CN)4]PF6 in degassed acetonitrile. A wavelength scan was 
performed using an Agilent 8453 spectrophotometer. This work was performed at the 
Chemistry Department of University of Leicester. 
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5.6.2 MALDI-TOF 
Proteins (1 µM) were buffer exchanged into 20 mM Tris pH 6.8 and treated with Cu(I)-
GSH as required prior to analysis. Sample aliquots were then added to a nonacidified 
sinpinic acid/H2O/acetonitrile matrix solution and spotted on a sample plate. Spectra 
were acquired using a calibrated MALDI-TOF mass spectrometer (Applied Biosystems 
Voyager-DE
TM
 PRO Biospectrometry Workstation).  Data were collected in the Mass 
Spectrometry Laboratory, The School of Pharmacy, University of London. 
5.6.3 nESI-MS 
 
Proteins (1 µM) were buffer exchanged into 50 mM ammonium acetate pH 7.5. A molar 
excess of Cu(I)-GSH complex was added to the protein solutions prior to analysis. Mass 
spectra were obtained on a QTof II MS (Waters) optimised for studying non-covalent 
interactions. Samples were introduced into the spectrometer using a gold-plated 
capillary needle (Harvard Apparatus).  This work was performed at the laboratory of 
Prof. Carol Robinson, Department of Chemistry, University of Oxford. 
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5.6.4 Estimation of copper affinity 
The copper affinity of DJ-1 was determined according to a previous method (Zhou et al., 
2008; Xiao et al., 2011;). Reduced apo-DJ-1 (25 µM dimer; untagged) in PBS was 
incubated with varying concentrations of Cu
I
(Bca)2
3-
 where Bca stands for 
bicinchoninic acid. The reaction mixtures were incubated for 10 minutes at room 
temperature to reach equilibrium. The equilibrium concentration of Cu
I
(Bca)2
3-
 was 
determined by measuring the absorbance at 562 nm using an Agilent 8453 
spectrophotometer. The dissociation constant of the Cu(I)-DJ-1 complex was calculated 
using the equation below (Xiao et al., 2011):  
 
where Kd = Cu(I)-DJ-1  dissociation constant 
β2 = Cu
I
(Bca)2
3-
 formation constant 
[P]total = total protein concentration as dimer 
[CuP] = Cu
I
(DJ-1)2  complex concentration 
[L]total = total Bca concentration and 
[CuL2] = Cu
I
(Bca)2
3-
 complex concentration 
 
5.6.5 Crystallisation and structure determination of Cu(I)-bound DJ-1 
  
His6-tagged DJ-1 crystals were obtained by mixing one volume of protein solution (15 
mg/ml) in 10 mM Tris pH 8.0, 75 mM NaCl, 3 mM DTT, 2.5% v/v glycerol with one 
volume of the reservoir solution (100 mM Tris pH 8.0, 10% w/v PEG 3350) using the 
hanging drop vapour diffusion method. The crystals were then soaked in the reservoir 
solution supplemented with 1 mM Cu(I)-GSH (1:3 molar ratio) complex, to get the 
Cu(I)-bound form of DJ-1. 
X-ray diffraction data were collected at beamline I0-3 at the Diamond Light Source. To 
obtain optimal measurements of the anomalous signal from the copper ion, the data 
were collected using a 1.3772 Å radiation source with 0.1° oscillation. Diffraction data 
were processed using the fast_dp protocol of XDS (Kabasch, 2010), POINTLESS and 
SCALA (Collaborative Computational Project, 1994). Molecular replacement using 
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PHASER
 
(McCoy et al., 2007) was carried out using 1PDV as the search model. 
Refinement and model building were performed using CCP4i REFMAC (Collaborative 
Computational Project, 1994; Murshudov et al., 1997) and COOT (Emsley P. and 
Cowtan K., 2004). The atomic coordinates and structure factors have been deposited in 
the Protein Data Bank (PDB ID: 4BTE). 
 
5.6.6 Crystallisation and structure determination of DJ-1 C106S bound to glycerol 
and sulphate anion 
 
Untagged DJ-1 C106S (phenyl-sepharose eluate) was buffer-exchanged into Buffer E 
once using a PD SpinTrap G-25 desalting column (GE Healthcare) and concentrated to 
12 mg/ml using an Amicon Ultra-4 centrifugal filter unit with 10 KDa MWCO Ultracel-
3 membrane (Millipore). Crystals were obtained by mixing one volume of the protein 
solution with one volume of the reservoir solution (20% v/v glycerol, 24% w/v PEG 
1500) using a hanging drop vapour diffusion method. Plate-like crystals grew overnight.   
Diffraction data were collected at 100 K using a Rigaku RU2HB X-ray generator 
equipped with a copper anode, Xenocs multilayer optics and an R-Axis IV detector. 
Data were indexed, integrated and scaled using MOSFLM (Leslie, 1992), POINTLESS 
and SCALA (Collaborative Computational Project, 1994). An initial model was 
obtained using PHASER (McCoy et al., 2007) with the 1.8 Å structure of DJ-1 (PDB 
ID: IPDV; Tao and Tong, 2003) as the search model. Refinement of the model was 
performed using phenix.refine. Electron densities for sulphate anion and glycerol in the 
active site were evident from the difference Fourier map. Manual adjustment and ligand 
fitting were performed in COOT (Emsley and Cowtan, 2004) and the structure figures 
were prepared using PyMOL (Delano, 2002).  
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5.6.7 Single crystal spectroscopy of Cu(I)-bound DJ-1 
 
Single crystal electronic absorption spectroscopy was performed at beamline I0-2 at the 
Diamond Light Source using an Andor303 imaging spectrograph with triple grating 
turret and Czerny-Turner geometry on an aperture setting of F/4 using a coupled 
aircooled Newton EM CCD and Maetel reflective lenses (Harwell, UK). Cu(I)-bound 
DJ-1 crystals were prepared by soaking the apo-DJ-1 crystals in reservoir solution (100 
mM Tris pH 8.0 and 10% (w/v) PEG 3350) supplemented with Cu(I)-GSH complex. 
Data were normalised based on protein content and a difference plot was obtained. For 
single crystal fluorescence, apo-DJ-1 crystals were soaked in reservoir solution 
containing either Cu(I)-GSH or 1 mM CuSO4 for 30 minutes. Spectra were recorded 
using a VortexEX fluorescence at the beamline I0-2 at Diamond Light Source. 
 
5.6.8 Circular dichroism (CD) spectroscopy 
Proteins (7.5 µM) in CD Buffer were transferred into a 0.5 – mm pathlength quartz 
cuvette. Far-UV CD spectra were recorded from 200-260 nm with 1 nm increments at 
20°C using a Chirascan-plus CD spectrometer (Applied Photophysics) at University of 
Leicester. 
5.6.9 Nuclear magnetic resonance (NMR) spectroscopy 
Uniformly 
15
N labelled proteins were buffer exchanged into 25 mM sodium phosphate 
buffer pH 6.5. Deuterium oxide was added to each protein solution to a final 
concentration of 10% v/v D2O. Heteronuclear single quantum correlation (HSQC) 
experiments for each protein (450 µM) were performed on a Bruker Avance III  500 
MHz NMR spectrometer at 25°C. The NMR data were processed using NMRpipe 
(Delaglio et al., 1995) and rendered using CCPNMR Analysis (Vranken et al., 2005).  
NMR experiments were performed at the  UCL Biomolecular NMR facility. 
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5.6.10 In vitro SOD1 activation assay 
A SOD1 assay was performed according to a method developed by Rae et al. (2001). 
Cu(I) was loaded into wild-type DJ-1 and the C53A variant by incubating the proteins 
in Cu(I)-GSH (1:5) complex under anaerobic conditions. Unbound copper was removed 
by buffer-exchanging the protein into TN buffer using a 0.5 ml desalting column 
(Pharmacia) at least twice. Proteins (20 µM) were quickly incubated with apo-SOD1 
(10 µM) for 30 minutes at 37°C. Reaction mixtures were then assayed for SOD1 
activity using a kit from Sigma based on the reduction of the tetrazolium salt WST-1 by 
xanthine oxidase-generated superoxide to give a yellow formazan dye which absorbs at 
490 nm (Figure 45).  
 
Figure 45. Chemical basis of the SOD1 activity assay. 
Experiments were set up as shown in Table 12. Absorbance (A) was recorded using a 
VersaMax microplate reader. SOD1 activity was calculated as the percent inhibition rate 
of WST-1 conversion to WST-1 formazan using the equation:  
 
Data (n = 3) were collected in three independent experiments. 
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Table 12. Preparation of reaction mixtures for SOD1 assay. 
 Sample Blank 1 Blank 2 Blank 3 
Reaction mixture 20 µl  20 µl  
Deionised water  20 µl  20 µl 
WST solution 200 µl 200 µl 200 ul 200 µl 
Enzyme solution 20 µl 20 µl   
Dilution buffer   20 µl 20 µl 
 
5.6.11 In vitro glyoxalase activity assay 
The glyoxalase activities of DJ-1 variants were determined following the procedure 
described in ref. 18. Proteins (2.5 nmol) in 100 mM sodium phosphate pH 6.8 were 
incubated with 5 mM of an aqueous solution of glyoxal at 42°C for 10 minutes. To 
quench the reaction, 0.1 % w/v 2,4-dinitrophenylhydrazine (DNPH) dissolved in 2 M 
HCl was diluted to 0.07% w/v with water and the solution was added to each reaction 
mixture. After 15 min incubation at room temperature, reactions were neutralized to 
3.44% w/v NaOH and incubated for another 15 minutes at room temperature. Each 
reaction mixture was diluted with blank solution (reaction mixture without substrate and 
protein) and the absorbance at 570 nm (εglyoxal, 570 nm = 2.571 mM
-1•cm-1) was measured. 
Each initial rate of reaction was measured by monitoring the decrease in substrate 
concentration. Initial rates of reaction were used to obtain Kcat values.  
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5.7 Cell-based assays 
5.7.1 Cell culture, transfections, and transductions 
Human neuroblastoma SH-SY5Y and DJ-1-null mouse embryonic fibroblasts (MEF 
DJ-1
-/-
) cells (a kind gift from Dr. Huaibin Cai, National Institute on Aging, NIH, 
Bethesda, USA) were grown in DMEM (Gibco) supplemented with 10% v/v foetal calf 
serum (Sigma), streptomycin (100 units/ml; Gibco), penicillin (100 units/ml; Gibco) 
and non-essential amino acids (Gibco).  
Cells were transiently transfected with DJ-1 constructs using Lipofectamine 2000 (Life 
Technologies) or xtremeGENE HP (Roche) using the manufacturer’s procedure. 
Plasmid DNA (2.5 µg per 10 cm
2
 well area) were incubated with the transfection 
reagent (3 µl per µg of DNA) at room temperature for 30 minutes. The transfection 
mixtures were then applied dropwise to each well with at least 70% cell confluency. 
Treated cells were incubated for at least 4 hours prior to replacement of media. Cells 
were assayed at least 24 hours post-transfection. The same protocol was also used for 
stable transfection except that stably transfected cells were selected with 100 µg/ml 
zeocin (Invitrogen) and subcultured for at least three weeks. 
Prior to transduction, cells were grown overnight to 70% confluency. Cells were then 
treated with 10 µM DJ-1 protein constructs with an N-terminal tat domain for at least 2 
hours at 37°C before assays were performed. Proteins were buffer exchanged into PBS 
and filter sterilised using a 0.22 micron syringe filter prior to application to cells. 
Protein transduction was confirmed using western blot analysis. 
5.7.2 Cell viability assays 
Cells were seeded in 96-well plates at 1 x 10
4
 and incubated for at least 24 hours. Cells 
were incubated with 10 µM tat-fused proteins in PBS for 2 hours to allow transduction 
and then treated with 2 mM of an aqueous solution of glyoxal for 18 hours to induce 
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cytotoxicity (Lee et al., 2012). Cell viability was measured using a PrestoBlue assay 
(Invitrogen).   
5.7.3 Immunoblotting 
Cells were lysed by adding 100 µl of 1X SDS-PAGE sample buffer (Sigma) into each 
well. Lysates were transferred to a microfuge tube, sonicated and heated at 95°C for 5 
minutes. Proteins were electrophoresed using SDS-PAGE and transferred onto a 
nitrocellulose membrane (GE Healthcare) by tank electroblotting using 1X Transfer 
Buffer. Each membrane was blocked with 5% w/v skimmed milk dissolved in TBS-T 
(Tris-buffered saline with 0.1% v/v Tween-20) for an hour and subsequently incubated 
with the appropriate primary antibody against DJ-1 (1 µg/ml; Enzo Life Sciences), 
penta-His (1/4000 dilution; Qiagen), β-actin (1/2000 dilution; Oncogene), or CML (1 
µg/ml ; R&D systems) prepared in 3% w/v BSA in TBS-T solution for an hour. Each 
membrane was washed twice with TBS-T and incubated with anti-mouse IgG antibody 
with horseradish peroxidase (1/8000 dilution; Sigma). Membranes were developed 
using an enhanced chemiluminescence kit (Thermo Scientific). 
5.7.4 Immununofluorescence 
Cells were washed once with PBS and fixed with 4% v/v formaldehyde in PBS for 20 
minutes at room temperature. Cells were then washed thrice with PBS-T. Cellular 
permeabilization was achieved by incubating the cells in ice cold methanol for 30 
minutes and then washed thrice with PBS-T. 5% w/v BSA in PBS-T was used to block 
each well for 15 minutes at room temperature. Cells were then incubated with the 
primary antibody against human DJ-1 (1 µg/ml; Enzo Life Sciences) for an hour 
followed by incubation with anti-mouse IgG antibody conjugated with Alexa Flour 488 
(Life Technologies) for another hour. To-Pro 3 (Life Technologies) was used to stain 
the nucleus. Micrographs were obtained using a Leica TCS SP2 confocal system (Leica 
Microsystems). Fluorescence was acquired using excitation wavelengths 488 nsm 
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(Alexa Fluor 488) and 633 nm (To-Pro-3) and emission bandwidths 500-550 nm (Alexa 
Fluor 488) and 650-720 nm (To-Pro-3). 
5.7.5 Measurement of intracellular superoxide levels and SOD1 activity 
SH-SY5Y cells (1 x 10
5
) were grown in 12-well plates for 48 hours. To induce increase 
the intracellular superoxide levels, cells were treated with 10 µM menadione dissolved 
in serum free media for 30 minutes. Cells were stained with 20 µM dihydroethidium 
(Life Technologies) for 10 minutes and analyzed using a FACScalibur flow cytometer. 
For intracellular SOD1 activity, cells were grown and treated with menadione as 
described above. Cytosolic extracts were prepared by lysing cells with PBS containing 
1% (v/v) Triton-X-100 and 0.5 mM EDTA followed by centrifugation at 10 000 x g to 
remove cellular debris. SOD1 was differentiated from SOD2 by adding 800 µl of 
chilled chloroform/ethanol [37.5/62.5 (v/v)] to 500 µl of cytosolic extract and then 
separating the two layers by centrifuging at 2500 x g for 10 minutes. The upper aqueous 
layer was assayed for SOD1 activity using an SOD assay kit (Sigma). 
5.7.6 Statistical analysis 
Experiments were performed at least twice independently. Statistical computations were 
performed using GraphPad QuickCalcs (http://www.graphpad.com/quickcalcs/) using 
continuous data analysis with unpaired t-test to compare difference between two means 
of independent samples. The significance limit was set to p < 0.001. 
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Appendix 1. Ex vivo SOD1 activation assay of DJ-1 ectopically expressed in MEF 
DJ-1
-/-
 cells. DJ-1 was ectopically expressed in MEF DJ-1
-/-
 cells and then isolated by 
immunoprecipitation using anti-DJ-1 antibody bound to Dynabeads. Apo-SOD1 was 
incubated with immunoprecipitated DJ-1 overnight at 4°C prior to measuring the SOD1 
activity using an assay kit (Sigma). SOD1 activity was measured as percent inhibition 
rate of WST-1 conversion to WST-1 formazan by the substrate superoxide. Error bars 
(red) represent SEM from data, n = 3. This experiment was performed by Dr. Benny 
Bjorkblom (Stavanger University Hospital) under the supervision of Prof. Simon Moller 
(St. John’s University and Stavanger University Hospital). 
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Appendix 2. DJ-1
A107P
 is not capable of homodimerisation but forms heterodimers 
with wild-type DJ-1. HEK 293E cells were transiently transfected with pCMV-myc-
DJ-1 and pCMV-HA-DJ-1 mutants. Myc-tagged DJ-1 proteins were isolated using anti-
myc agarose beads. Co-immunoprecipitated HA-tagged DJ-1 was detected using 
western blot analysis. This experiment was performed by Emmy Rannikko (University 
of Tuebingen) under the supervision of Prof. Philipp Kahle (Univeristy of Tuebingen). 
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Appendix 3. DJ-1
A107P
 has reduced protein steady state levels in HEK 293E and 
MEF cells. Upper panel: HEK 293E, MEF DJ-1
+/+
, MEF DJ-1
-/-
 were transfected with 
pCMV-myc-DJ-1 or empty vector. Ectopicallyl expressed DJ-1 proteins were detected 
by western blot analysis using DJ-1 and myc specific antibodies. GAPDH  was 
immunodetected as a loading control. Lower panel: RT-PCR using primers specific for 
human DJ-1 was performed to show equal mRNA expression levels. β-actin and 
HPBDG serve as controls for equal sample loading. This experiment was performed by 
Emmy Rannikko (University of Tuebingen) under the supervision of Prof. Philipp 
Kahle (Univeristy of Tuebingen). 
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